Publications

Publications published since 2000 from OUS - Department of Pharmacology

400 publications found

Publications 2020

1. Arzimanoglou A, Brandl U, Cross JH, Gil-Nagel A, Lagae L, Landmark CJ, Specchio N, Nabbout R, Thiele EA, Gubbay O, The Cannabinoids International Experts Panel, Collaborators (2020)
   Epilepsy and cannabidiol: a guide to treatment
   Epileptic Disord, 22 (1), 1-14
   DOI 10.1684/epd.2020.1141, PubMed 32096470
2. Bejder J, Breenfeldt Andersen A, Bonne TC, Piil JF, Hagen LCH, Dehnes Y, Eibye KH, Nybo L, Nordsborg NB (2020)
   Tramadol Does Not Improve Performance or Impair Motor Function in Trained Cyclists
   Med Sci Sports Exerc, 52 (5), 1169-1175
   DOI 10.1249/MSS.0000000000002217, PubMed 31809408
3. Egeland EJ, Witczak BJ, Zaré HK, Christensen H, Åsberg A, Robertsen I (2020)
   Chronic Inhibition of CYP3A is Temporarily Reduced by Each Hemodialysis Session in Patients With End-Stage Renal Disease
   Clin Pharmacol Ther
   DOI 10.1002/cpt.1875, PubMed 32356565
4. Elens L, Langman LJ, Hesselink DA, Bergan S, Moes DJAR, Molinaro M, Venkataramanan R, Lemaitre F (2020)
   Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions
   Ther Drug Monit, 42 (3), 360-368
   DOI 10.1097/FTD.0000000000000761, PubMed 32304488
5. Franco V, Gatti G, Mazzucchelli I, Marchiselli R, Fattore C, Rota P, Galimberti CA, Capovilla G, Beccaria F, De Giorgis V, Johannessen Landmark C, Perucca E (2020)
   Relationship between saliva and plasma rufinamide concentrations in patients with epilepsy
   Epilepsia
   DOI 10.1111/epi.16584, PubMed 32562438
6. Gustavsen MT, Midtvedt K, Vethe NT, Robertsen I, Bergan S, Åsberg A (2020)
   Tacrolimus Area Under the Concentration Versus Time Curve Monitoring, Using Home-Based Volumetric Absorptive Capillary Microsampling
   Ther Drug Monit, 42 (3), 407-414
   DOI 10.1097/FTD.0000000000000697, PubMed 31479042
7. Halaas NB, Henjum K, Blennow K, Dakhil S, Idland AV, Nilsson LN, Sederevicius D, Vidal-Piñeiro D, Walhovd KB, Wyller TB, Zetterberg H, Watne LO, Fjell AM (2020)
   CSF sTREM2 and Tau Work Together in Predicting Increased Temporal Lobe Atrophy in Older Adults
   Cereb Cortex, 30 (4), 2295-2306
   DOI 10.1093/cercor/bhz240, PubMed 31812991
8. Hemmersbach P (2020)
   The Probenecid-story - A success in the fight against doping through out-of-competition testing
   Drug Test Anal, 12 (5), 589-594
   DOI 10.1002/dta.2727, PubMed 31797550
9. Henjum K, Årskog V, Jendresen CB, Fladby T, Torp R, Nilsson LNG (2020)
   Analyzing microglial-associated Aβ in Alzheimer's disease transgenic mice with a novel mid-domain Aβ-antibody
   Sci Rep, 10 (1), 10590
   DOI 10.1038/s41598-020-67419-2, PubMed 32601313
10. Johannessen Landmark C, Johannessen SI, Patsalos PN (2020)
    Therapeutic drug monitoring of antiepileptic drugs: current status and future prospects
    Expert Opin Drug Metab Toxicol, 16 (3), 227-238
    DOI 10.1080/17425255.2020.1724956, PubMed 32054370
11. Klaasen RA, Bergan S, Bremer S, Hole K, Nordahl CB, Andersen AM, Midtvedt K, Skauby MH, Vethe NT (2020)
    Pharmacodynamic assessment of mycophenolic acid in resting and activated target cell population during the first year after renal transplantation
    Br J Clin Pharmacol, 86 (6), 1100-1112
    DOI 10.1111/bcp.14218, PubMed 31925806
12. Kristiansen O, Vethe NT, Peersen K, Fagerland MW, Sverre E, Jensen EP, Lindberg M, Gjertsen E, Gullestad L, Perk J, Dammen T, Bergan S, Husebye E, Otterstad JE, Munkhaugen J (2020)
    Effect of atorvastatin on muscle symptoms in coronary heart disease patients with self-perceived statin muscle side-effects: a randomized, double blinded crossover trial
    Eur Heart J Cardiovasc Pharmacother (in press)
    DOI 10.1093/ehjcvp/pvaa076, PubMed 32609361
13. Landmark CJ, Heger K, Lund C, Burns ML, Bjørnvold M, Sætre E, Johannessen SI (2020)
    Pharmacokinetic variability during long-term therapeutic drug monitoring of valproate, clobazam, and levetiracetam in patients with Dravet syndrome
    Ther Drug Monit (in press)
    DOI 10.1097/FTD.0000000000000781, PubMed 32558674
14. Lau C, McAdam MB, Bergseth G, Grevys A, Bruun JA, Ludviksen JK, Fure H, Espevik T, Moen A, Andersen JT, Mollnes TE (2020)
    NHDL, a recombinant V_L/V_H hybrid antibody control for IgG2/4 antibodies
    MAbs, 12 (1), 1686319
    DOI 10.1080/19420862.2019.1686319, PubMed 31671278
15. Lemaitre F, Vethe NT, D'Avolio A, Tron C, Robertsen I, De Winter B, Denicolo A, Koch BCP, Venkataramanan R, Van Gelder T, Brunet M, Bergan S, Hesselink DA, Wallemacq P (2020)
    Measuring Intracellular Concentrations of Calcineurin Inhibitors: Expert Consensus from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) Expert Panel
    Ther Drug Monit (in press)
    DOI 10.1097/FTD.0000000000000780, PubMed 32520841
16. Mullen J, Baekken LV, Törmäkangas T, Ekström L, Ericsson M, Hullstein IR, Schulze JJ (2020)
    Inter-individual variation of the urinary steroid profiles in Swedish and Norwegian athletes
    Drug Test Anal, 12 (6), 720-730
    DOI 10.1002/dta.2778, PubMed 32052600
17. Solheim SA, Jessen S, Mørkeberg J, Thevis M, Dehnes Y, Eibye K, Hostrup M, Nordsborg NB (2020)
    Single-dose administration of clenbuterol is detectable in dried blood spots
    Drug Test Anal
    DOI 10.1002/dta.2872, PubMed 32495983
18. Solheim SA, Mørkeberg J, Dehnes Y, Hullstein I, Juul A, Upners EN, Nordsborg NB (2020)
    Changes in blood parameters after intramuscular testosterone ester injections - Implications for anti-doping
    Drug Test Anal
    DOI 10.1002/dta.2803, PubMed 32307878
19. Svendsen T, Brodtkorb E, Baftiu A, Lossius MI, Nakken KO, Johannessen SI, Johannessen Landmark C (2020)
    Clinical experience combined with therapeutic drug monitoring of lacosamide
    Acta Neurol Scand, 141 (4), 279-286
    DOI 10.1111/ane.13206, PubMed 31853958
20. Torp HA, Nystoyl B (2020)
    Neutropenia in treatment with antipsychotics
    Tidsskr. Nor. Laegeforen., 140 (8), 793-795
21. Torp HA, Nystøyl B (2020)
    Nøytropeni ved behandling med antipsykotika
    Tidsskr Nor Laegeforen, 140 (8)
    DOI 10.4045/tidsskr.19.0713, PubMed 32463195

Publications 2019

1. Andreassen BK, Støer NC, Martinsen JI, Ursin G, Weiderpass E, Thoresen GH, Debernard KB, Karlstad Ø, Pottegard A, Friis S (2019)
   Identification of potential carcinogenic and chemopreventive effects of prescription drugs: a protocol for a Norwegian registry-based study
   BMJ Open, 9 (4), e028504
   DOI 10.1136/bmjopen-2018-028504, PubMed 30962244
2. Baftiu A, Lima MH, Svendsen K, Larsson PG, Johannessen SI, Landmark CJ (2019)
   Safety aspects of antiepileptic drugs-a population-based study of adverse effects relative to changes in utilisation
   Eur J Clin Pharmacol, 75 (8), 1153-1160
   DOI 10.1007/s00228-019-02678-1, PubMed 31001654
3. Bergström M, Müller M, Karlsson M, Scholz H, Vethe NT, Korsgren O (2019)
   Comparing the Effects of the mTOR Inhibitors Azithromycin and Rapamycin on In Vitro Expanded Regulatory T Cells
   Cell Transplant, 28 (12), 1603-1613
   DOI 10.1177/0963689719872488, PubMed 31512504
4. Bialer M, Johannessen SI, Koepp MJ, Levy RH, Perucca E, Tomson T, White HS (2019)
   A summary of data presented at the XIV conference on new antiepileptic drug and devices (EILAT XIV)
   Epilepsy Res, 153, 66-67
   DOI 10.1016/j.eplepsyres.2019.03.002, PubMed 30910314
5. Blom KB, Bergo KK, Espe EKS, Rosseland V, Grøtta OJ, Mjøen G, Åsberg A, Bergan S, Sanner H, Bergersen TK, Bjørnerheim R, Skauby M, Seljeflot I, Waldum-Grevbo B, Dahle DO, Sjaastad I, Birkeland JA (2019)
   Cardiovascular rEmodelling in living kidNey donorS with reduced glomerular filtration rate: rationale and design of the CENS study
   Blood Press, 29 (2), 123-134
   DOI 10.1080/08037051.2019.1684817, PubMed 31718316
6. Bottermann M, Foss S, Caddy SL, Clift D, van Tienen LM, Vaysburd M, Cruickshank J, O'Connell K, Clark J, Mayes K, Higginson K, Lode HE, McAdam MB, Sandlie I, Andersen JT, James LC (2019)
   Complement C4 Prevents Viral Infection through Capsid Inactivation
   Cell Host Microbe, 25 (4), 617-629.e7
   DOI 10.1016/j.chom.2019.02.016, PubMed 30926239
7. Brunet M, van Gelder T, Åsberg A, Haufroid V, Hesselink DA, Langman L, Lemaitre F, Marquet P, Seger C, Shipkova M, Vinks A, Wallemacq P, Wieland E, Woillard JB, Barten MJ, Budde K, Colom H, Dieterlen MT, Elens L, Johnson-Davis KL, Kunicki PK, MacPhee I, Masuda S, Mathew BS, Millán O et al. (2019)
   Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report
   Ther Drug Monit, 41 (3), 261-307
   DOI 10.1097/FTD.0000000000000640, PubMed 31045868
8. Bruun LD, Kjeldstadli K, Temte V, Birdal M, Bachs L, Langødegård M, Strand DH, Gaare KI, Øiestad E, Høiseth G (2019)
   Detection Time of Oxazepam and Zopiclone in Urine and Oral Fluid after Experimental Oral Dosing
   J Anal Toxicol, 43 (5), 369-377
   DOI 10.1093/jat/bky083, PubMed 30615130
9. Bull Melsom C, Cosson MV, Ørstavik Ø, Lai NC, Hammond HK, Osnes JB, Skomedal T, Nikolaev V, Levy FO, Krobert KA (2019)
   Constitutive inhibitory G protein activity upon adenylyl cyclase-dependent cardiac contractility is limited to adenylyl cyclase type 6
   PLoS One, 14 (6), e0218110
   DOI 10.1371/journal.pone.0218110, PubMed 31173603
10. Calamera G, Li D, Ulsund AH, Kim JJ, Neely OC, Moltzau LR, Bjørnerem M, Paterson D, Kim C, Levy FO, Andressen KW (2019)
    FRET-based cyclic GMP biosensors measure low cGMP concentrations in cardiomyocytes and neurons
    Commun Biol, 2, 394
    DOI 10.1038/s42003-019-0641-x, PubMed 31701023
11. Cosson MV, Hiis HG, Moltzau LR, Levy FO, Krobert KA (2019)
    Knockout of adenylyl cyclase isoform 5 or 6 differentially modifies the β₁-adrenoceptor-mediated inotropic response
    J Mol Cell Cardiol, 131, 132-145
    DOI 10.1016/j.yjmcc.2019.04.017, PubMed 31009605
12. Danese E, Raimondi S, Montagnana M, Tagetti A, Langaee T, Borgiani P, Ciccacci C, Carcas AJ, Borobia AM, Tong HY, Dávila-Fajardo C, Rodrigues Botton M, Bourgeois S, Deloukas P, Caldwell MD, Burmester JK, Berg RL, Cavallari LH, Drozda K, Huang M, Zhao LZ, Cen HJ, Gonzalez-Conejero R, Roldan V, Nakamura Y et al. (2019)
    Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals
    Clin Pharmacol Ther, 105 (6), 1477-1491
    DOI 10.1002/cpt.1323, PubMed 30506689
13. Foss S, Bottermann M, Jonsson A, Sandlie I, James LC, Andersen JT (2019)
    TRIM21-From Intracellular Immunity to Therapy
    Front Immunol, 10, 2049
    DOI 10.3389/fimmu.2019.02049, PubMed 31555278
14. Frost J, Bernard JP, Dietrichs ES, Kjeldstadli K, Riedel B, Skrastad RB, Vevelstad M, Helland A (2019)
    New recommendations for serum concentration measurements of central stimulant drugs
    Tidsskr. Nor. Laegeforen., 139 (13), 1230-1231
15. Granas AG, Halvorsen KH, Wendelbo J, Johannessen Landmark C (2019)
    Interdisciplinary medication review to improve pharmacotherapy for patients with intellectual disabilities
    Int J Clin Pharm, 41 (6), 1516-1525
    DOI 10.1007/s11096-019-00914-3, PubMed 31729635
16. Havnen GC, Truong MB, Do MH, Heitmann K, Holst L, Nordeng H (2019)
    Women's perspectives on the management and consequences of hyperemesis gravidarum - a descriptive interview study
    Scand J Prim Health Care, 37 (1), 30-40
    DOI 10.1080/02813432.2019.1569424, PubMed 30822254
17. Henning O, Johannessen Landmark C, Nakken KO, Lossius MI (2019)
    Nonadherence to treatment regimens in epilepsy from the patient's perspective and predisposing factors: Differences between intentional and unintentional lack of adherence
    Epilepsia, 60 (5), e58-e62
    DOI 10.1111/epi.14734, PubMed 30980675
18. Henning O, Johannessen Landmark C, Traeen B, Svendsen T, Farmen A, Nakken KO, Lossius M (2019)
    Sexual function in people with epilepsy: Similarities and differences with the general population
    Epilepsia, 60 (9), 1984-1992
    DOI 10.1111/epi.16311, PubMed 31407332
19. Henning O, Landmark CJ, Henning D, Nakken KO, Lossius MI (2019)
    Challenges in epilepsy-The perspective of Norwegian epilepsy patients
    Acta Neurol Scand, 140 (1), 40-47
    DOI 10.1111/ane.13098, PubMed 30963535
20. Henning O, Lossius MI, Lima M, Mevåg M, Villagran A, Nakken KO, Johannessen Landmark C (2019)
    Refractory epilepsy and nonadherence to drug treatment
    Epilepsia Open, 4 (4), 618-623
    DOI 10.1002/epi4.12367, PubMed 31819918
21. Jendresen C, Digre A, Cui H, Zhang X, Vlodavsky I, Li JP, Nilsson LNG (2019)
    Systemic LPS-induced Aβ-solubilization and clearance in AβPP-transgenic mice is diminished by heparanase overexpression
    Sci Rep, 9 (1), 4600
    DOI 10.1038/s41598-019-40999-4, PubMed 30872722
22. Johannessen Landmark C, Fløgstad I, Baftiu A, Syvertsen M, Enger U, Koht J, Johannessen SI (2019)
    Long-term follow-up with therapeutic drug monitoring of antiepileptic drugs in patients with juvenile myoclonic epilepsy
    Epilepsy Res, 155, 106148
    DOI 10.1016/j.eplepsyres.2019.05.016, PubMed 31195184
23. Johannessen Landmark C, Fløgstad I, Syvertsen M, Baftiu A, Enger U, Koht J, Johannessen SI (2019)
    Treatment and challenges with antiepileptic drugs in patients with juvenile myoclonic epilepsy
    Epilepsy Behav, 98 (Pt A), 110-116
    DOI 10.1016/j.yebeh.2019.05.021, PubMed 31330379
24. Klaasen RA, Egeland EJ, Chan J, Midtvedt K, Svensson M, Bolstad N, Fellström B, Holdaas H, Åsberg A, Bergan S, Vethe NT, Warren DJ (2019)
    A Fully Automated Method for the Determination of Serum Belatacept and Its Application in a Pharmacokinetic Investigation in Renal Transplant Recipients
    Ther Drug Monit, 41 (1), 11-18
    DOI 10.1097/FTD.0000000000000580, PubMed 30633722
25. Kristiansen O, Vethe NT, Fagerland MW, Bergan S, Munkhaugen J, Husebye E (2019)
    A novel direct method to determine adherence to atorvastatin therapy in patients with coronary heart disease
    Br J Clin Pharmacol, 85 (12), 2878-2885
    DOI 10.1111/bcp.14122, PubMed 31495943
26. Labzin LI, Bottermann M, Rodriguez-Silvestre P, Foss S, Andersen JT, Vaysburd M, Clift D, James LC (2019)
    Antibody and DNA sensing pathways converge to activate the inflammasome during primary human macrophage infection
    EMBO J, 38 (21), e101365
    DOI 10.15252/embj.2018101365, PubMed 31468569
27. Labzin LI, Bottermann M, Rodriguez-Silvestre P, Foss S, Andersen JT, Vaysburd M, Clift D, James LC (2019)
    Antibody and DNA sensing pathways converge to activate the inflammasome during primary human macrophage infection
    Embo J., 38 (21), e101365
28. Larsen Burns M, Kinge E, Stokke Opdal M, Johannessen SI, Johannessen Landmark C (2019)
    Therapeutic drug monitoring of gabapentin in various indications
    Acta Neurol Scand, 139 (5), 446-454
    DOI 10.1111/ane.13075, PubMed 30710348
29. Larsen Burns M, Nikanorova M, Baftiu A, Borg Rasmussen J, Johannessen SI, Johannessen Landmark C (2019)
    Pharmacokinetic Variability and Clinical Use of Lacosamide in Children and Adolescents in Denmark and Norway
    Ther Drug Monit, 41 (3), 340-347
    DOI 10.1097/FTD.0000000000000599, PubMed 30688870
30. Lode HE, Gjølberg TT, Foss S, Sivertsen MS, Brustugun J, Andersson Y, Jørstad ØK, Moe MC, Andersen JT (2019)
    A new method for pharmaceutical compounding and storage of anti-VEGF biologics for intravitreal use in silicone oil-free prefilled plastic syringes
    Sci Rep, 9 (1), 18021
    DOI 10.1038/s41598-019-54226-7, PubMed 31792234
31. Munkhaugen J, Vethe NT, Fagerland MW, Dammen T, Perk J, Gjertsen E, Otterstad JE, Gullestad L, Bergan S, Husebye E (2019)
    Statin-associated muscle symptoms in coronary patients: design of a randomized study
    Scand Cardiovasc J, 53 (3), 162-168
    DOI 10.1080/14017431.2019.1612085, PubMed 31030568
32. Maaland AF, Heyerdahl H, O'Shea A, Eiriksdottir B, Pascal V, Andersen JT, Kolstad A, Dahle J (2019)
    Targeting B-cell malignancies with the beta-emitting anti-CD37 radioimmunoconjugate ¹⁷⁷Lu-NNV003
    Eur J Nucl Med Mol Imaging, 46 (11), 2311-2321
    DOI 10.1007/s00259-019-04417-1, PubMed 31309259
33. Ndongson-Dongmo B, Lang GP, Mece O, Hechaichi N, Lajqi T, Hoyer D, Brodhun M, Heller R, Wetzker R, Franz M, Levy FO, Bauer R (2019)
    Reduced ambient temperature exacerbates SIRS-induced cardiac autonomic dysregulation and myocardial dysfunction in mice
    Basic Res Cardiol, 114 (3), 26
    DOI 10.1007/s00395-019-0734-1, PubMed 31016449
34. Nordengen K, Kirsebom BE, Henjum K, Selnes P, Gísladóttir B, Wettergreen M, Torsetnes SB, Grøntvedt GR, Waterloo KK, Aarsland D, Nilsson LNG, Fladby T (2019)
    Glial activation and inflammation along the Alzheimer's disease continuum
    J Neuroinflammation, 16 (1), 46
    DOI 10.1186/s12974-019-1399-2, PubMed 30791945
35. Pyzik M, Sand KMK, Hubbard JJ, Andersen JT, Sandlie I, Blumberg RS (2019)
    The Neonatal Fc Receptor (FcRn): A Misnomer?
    Front Immunol, 10, 1540
    DOI 10.3389/fimmu.2019.01540, PubMed 31354709
36. Skulberg AK, Åsberg A, Khiabani HZ, Røstad H, Tylleskar I, Dale O (2019)
    Pharmacokinetics of a novel, approved, 1.4-mg intranasal naloxone formulation for reversal of opioid overdose-a randomized controlled trial
    Addiction, 114 (5), 859-867
    DOI 10.1111/add.14552, PubMed 30644628
37. Sørensen O, Andersen AM, Larsen SG, Giercksky KE, Flatmark K (2019)
    Intraperitoneal mitomycin C improves survival compared to cytoreductive surgery alone in an experimental model of high-grade pseudomyxoma peritonei
    Clin Exp Metastasis, 36 (6), 511-518
    DOI 10.1007/s10585-019-09991-0, PubMed 31541325
38. Temte V, Kjeldstadli K, Bruun LD, Birdal M, Bachs L, Karinen R, Middelkoop G, Øiestad E, Høiseth G (2019)
    An Experimental Study of Diazepam and Alprazolam Kinetics in Urine and Oral Fluid Following Single Oral Doses
    J Anal Toxicol, 43 (2), 104-111
    DOI 10.1093/jat/bky062, PubMed 30517712
39. Traaen GM, Øverland B, Aakerøy L, Hunt TE, Bendz C, Sande L, Aakhus S, Zaré H, Steinshamn S, Anfinsen OG, Loennechen JP, Gullestad L, Akre H (2019)
    Prevalence, risk factors, and type of sleep apnea in patients with paroxysmal atrial fibrillation
    Int J Cardiol Heart Vasc, 26, 100447
    DOI 10.1016/j.ijcha.2019.100447, PubMed 32140547
40. Tuv SS, Vethe NT, Bergan S, Nordal K (2019)
    Pharmacogenetics in personalised drug therapy
    Tidsskr. Nor. Laegeforen., 139 (8), 700-702
41. Vethe NT, Gustavsen MT, Midtvedt K, Lauritsen ME, Andersen AM, Åsberg A, Bergan S (2019)
    Tacrolimus Can Be Reliably Measured With Volumetric Absorptive Capillary Microsampling Throughout the Dose Interval in Renal Transplant Recipients
    Ther Drug Monit, 41 (5), 607-614
    DOI 10.1097/FTD.0000000000000655, PubMed 31584926
42. Vethe NT, Munkhaugen J, Andersen AM, Husebye E, Bergan S (2019)
    A Method for Direct Monitoring of Atorvastatin Adherence in Cardiovascular Disease Prevention: Quantification of the Total Exposure to Parent Drug and Major Metabolites Using 2-Channel Chromatography and Tandem Mass Spectrometry
    Ther Drug Monit, 41 (1), 19-28
    DOI 10.1097/FTD.0000000000000578, PubMed 30633723
43. Westergren T, Narum S, Klemp M (2019)
    Critical appraisal of adverse effects reporting in the 'Treatment for Adolescents With Depression Study (TADS)'
    BMJ Open, 9 (3), e026089
    DOI 10.1136/bmjopen-2018-026089, PubMed 30878988

Publications 2018

1. Andressen KW, Ulsund AH, Krobert KA, Lohse MJ, Bünemann M, Levy FO (2018)
   Related GPCRs couple differently to G_s: preassociation between G protein and 5-HT₇ serotonin receptor reveals movement of Gα_s upon receptor activation
   FASEB J, 32 (2), 1059-1069
   DOI 10.1096/fj.201700486R, PubMed 29079700
2. Bialer M, Johannessen SI, Koepp MJ, Levy RH, Perucca E, Tomson T, White HS (2018)
   Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). II. Drugs in more advanced clinical development
   Epilepsia, 59 (10), 1842-1866
   DOI 10.1111/epi.14555, PubMed 30368788
3. Bialer M, Johannessen SI, Koepp MJ, Levy RH, Perucca E, Tomson T, White HS (2018)
   Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). I. Drugs in preclinical and early clinical development
   Epilepsia, 59 (10), 1811-1841
   DOI 10.1111/epi.14557, PubMed 30368792
4. Eek AK, Strøm BO, Bakkehøi G, Stenberg-Nilsen H (2018)
   Anticoagulant-associated adverse drug reactions in 2013-15
   Tidsskr Nor Laegeforen, 138 (12)
   DOI 10.4045/tidsskr.17.0706, PubMed 30132616
5. Egeland EJ, Størset E, Robertsen I, Hermann M, Midtvedt K, Gustavsen MT, Klaasen R, Bergan S, Hartmann A, Åsberg A (2018)
   The Authors' Reply
   Transplantation, 102 (1), e43-e44
   DOI 10.1097/TP.0000000000001961, PubMed 28957846
6. Eide IA, Reinholt FP, Jenssen T, Hartmann A, Schmidt EB, Åsberg A, Bergan S, Brabrand K, Svensson M (2018)
   Effects of marine n-3 fatty acid supplementation in renal transplantation: A randomized controlled trial
   Am J Transplant, 19 (3), 790-800
   DOI 10.1111/ajt.15080, PubMed 30125457
7. Fjeld H, Stylianou E (2018)
   Hypersensitivity reactions with prolonged infusions of β-lactams?
   Clin Microbiol Infect, 25 (1), 121-122
   DOI 10.1016/j.cmi.2018.08.021, PubMed 30195470
8. Grevys A, Nilsen J, Sand KMK, Daba MB, Øynebråten I, Bern M, McAdam MB, Foss S, Schlothauer T, Michaelsen TE, Christianson GJ, Roopenian DC, Blumberg RS, Sandlie I, Andersen JT (2018)
   A human endothelial cell-based recycling assay for screening of FcRn targeted molecules
   Nat Commun, 9 (1), 621
   DOI 10.1038/s41467-018-03061-x, PubMed 29434196
9. Havig SM, Lea D, Krpo M, Skari RM, Gustavsen I, Høiseth G (2018)
   Fatal Adverse Event with Dabigatran in Elderly Patient with Reduced Kidney Function
   Basic Clin Pharmacol Toxicol, 123 (2), 221-226
   DOI 10.1111/bcpt.12985, PubMed 29438599
10. Heldal K, Midtvedt K, Hartmann A, Reisaeter AV, Heldal TF, Bergan S, Salvador CL, Åsberg A (2018)
    Estimated glomerular filtration rate in stable older kidney transplant recipients-are present algorithms valid? A national cross-sectional cohort study
    Transpl Int, 31 (6), 629-638
    DOI 10.1111/tri.13137, PubMed 29453878
11. Henjum K, Quist-Paulsen E, Zetterberg H, Blennow K, Nilsson LNG, Watne LO (2018)
    CSF sTREM2 in delirium-relation to Alzheimer's disease CSF biomarkers Aβ42, t-tau and p-tau
    J Neuroinflammation, 15 (1), 304
    DOI 10.1186/s12974-018-1331-1, PubMed 30390679
12. Hiis HG, Cosson MV, Dahl CP, Fiane AE, Levy FO, Andersen GØ, Krobert KA (2018)
    Hypothermia elongates the contraction-relaxation cycle in explanted human failing heart decreasing the time for ventricular filling during diastole
    Am J Physiol Heart Circ Physiol, 315 (5), H1137-H1147
    DOI 10.1152/ajpheart.00208.2018, PubMed 30004809
13. Hov KR, Neerland BE, Andersen AM, Undseth Ø, Wyller VB, MacLullich AMJ, Skovlund E, Qvigstad E, Wyller TB (2018)
    The use of clonidine in elderly patients with delirium; pharmacokinetics and hemodynamic responses
    BMC Pharmacol Toxicol, 19 (1), 29
    DOI 10.1186/s40360-018-0218-1, PubMed 29884231
14. Johannessen Landmark C, Farmen AH, Burns ML, Baftiu A, Lossius MI, Johannessen SI, Tomson T (2018)
    Pharmacokinetic variability of valproate during pregnancy - Implications for the use of therapeutic drug monitoring
    Epilepsy Res, 141, 31-37
    DOI 10.1016/j.eplepsyres.2018.02.004, PubMed 29453075
15. Klaasen RA, Bergan S, Bremer S, Daleq L, Andersen AM, Midtvedt K, Skauby MH, Vethe NT (2018)
    Longitudinal Study of Tacrolimus in Lymphocytes During the First Year After Kidney Transplantation
    Ther Drug Monit, 40 (5), 558-566
    DOI 10.1097/FTD.0000000000000539, PubMed 30086087
16. Krogstad V, Vethe NT, Robertsen I, Hasvold G, Ose AD, Hermann M, Andersen AM, Chan J, Skauby M, Svensson MHS, Åsberg A, Christensen H (2018)
    Determination of Tacrolimus Concentration and Protein Expression of P-Glycoprotein in Single Human Renal Core Biopsies
    Ther Drug Monit, 40 (3), 292-300
    DOI 10.1097/FTD.0000000000000510, PubMed 29578937
17. Krug O, Thomas A, Malerød-Fjeld H, Dehnes Y, Laussmann T, Feldmann I, Sickmann A, Thevis M (2018)
    Analysis of new growth promoting black market products
    Growth Horm IGF Res, 41, 1-6
    DOI 10.1016/j.ghir.2018.05.001, PubMed 29864719
18. Munkhaugen J, Ruddox V, Halvorsen S, Dammen T, Fagerland MW, Hernæs KH, Vethe NT, Prescott E, Jensen SE, Rødevand O, Jortveit J, Bendz B, Schirmer H, Køber L, Bøtker HE, Larsen AI, Vikenes K, Steigen T, Wiseth R, Pedersen T, Edvardsen T, Otterstad JE, Atar D (2018)
    BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study
    Am Heart J, 208, 37-46
    DOI 10.1016/j.ahj.2018.10.005, PubMed 30530121
19. Müller LD, Opdal MS (2018)
    Developing a rapid semi-automated sample preparation with alkaline hydrolysis in a 96-well plate for quantification of 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid in urine samples by UHPLC-MS/MS
    J Pharm Biomed Anal, 161, 296-304
    DOI 10.1016/j.jpba.2018.08.045, PubMed 30189411
20. Nilsen J, Sandlie I, Roopenian DC, Andersen JT (2018)
    Animal models for evaluation of albumin-based therapeutics
    Curr. Opin. Chem. Eng., 19, 68-76
21. Reimers A, Berg JA, Burns ML, Brodtkorb E, Johannessen SI, Johannessen Landmark C (2018)
    Reference ranges for antiepileptic drugs revisited: a practical approach to establish national guidelines
    Drug Des Devel Ther, 12, 271-280
    DOI 10.2147/DDDT.S154388, PubMed 29467570
22. Reiter L, Stenberg-Nilsen H (2018)
    Too high vitamin D content in dietary supplements?
    Tidsskr. Nor. Laegeforen., 138 (1), 20-21
23. Serk TT, Le Nygaard I, Kvan E, Frost J, Aronsen L, Narum S, Bjanes T (2018)
    Immediate telephonic alerting of deviating pharmacological test results
    Tidsskr. Nor. Laegeforen., 138 (18), 1694-1695
24. Skogestad J, Aronsen JM (2018)
    Hypokalemia-Induced Arrhythmias and Heart Failure: New Insights and Implications for Therapy
    Front Physiol, 9, 1500
    DOI 10.3389/fphys.2018.01500, PubMed 30464746
25. Stapleton NM, Armstrong-Fisher SS, Andersen JT, van der Schoot CE, Porter C, Page KR, Falconer D, de Haas M, Williamson LM, Clark MR, Vidarsson G, Armour KL (2018)
    Human IgG lacking effector functions demonstrate lower FcRn-binding and reduced transplacental transport
    Mol Immunol, 95, 1-9
    DOI 10.1016/j.molimm.2018.01.006, PubMed 29367080
26. Syvertsen M, Fløgstad I, Enger U, Landmark CJ, Koht J (2018)
    Antiepileptic drug withdrawal in juvenile myoclonic epilepsy
    Acta Neurol Scand, 139 (2), 192-198
    DOI 10.1111/ane.13042, PubMed 30378684
27. Traaen GM, Aakerøy L, Hunt TE, Øverland B, Lyseggen E, Aukrust P, Ueland T, Helle-Valle T, Steinshamn S, Edvardsen T, Khiabani Zaré H, Aakhus S, Akre H, Anfinsen OG, Loennechen JP, Gullestad L (2018)
    Treatment of sleep apnea in patients with paroxysmal atrial fibrillation: design and rationale of a randomized controlled trial
    Scand Cardiovasc J, 52 (6), 372-377
    DOI 10.1080/14017431.2019.1567933, PubMed 30638392
28. Tvete IF, Bjørner T, Skomedal T (2018)
    Mental Health and Disability Pension Onset: Changes in Consumption of Antianxiety and Hypnotic Drugs
    Health Serv Res Manag Epidemiol, 5, 2333392818792683
    DOI 10.1177/2333392818792683, PubMed 30182036

Publications 2017

1. Ahamed M, Vermeulen K, Schnekenburger M, Moltzau LR, Levy FO, Marton J, Froeyen M, Olberg DE, Diederich M, Bormans G (2017)
   Synthesis, Enzyme Assays and Molecular Docking Studies of Fluorinated Bioisosteres of Santacruzamate A as Potential HDAC Tracers
   Lett. Drug Des. Discov., 14 (7), 787-797
2. Ask IS, Føreid S, Knatten CK, Wallace SC, Gadeholt G (2017)
   [Detection of nitromethane in blood]
   Tidsskr Nor Laegeforen, 137 (2), 112
   DOI 10.4045/tidsskr.16.0100, PubMed 28127074
3. Baftiu A, Feet SA, Larsson PG, Burns ML, Henning O, Sætre E, Molden E, Granas AG, Johannessen SI, Landmark CJ (2017)
   Utilisation and polypharmacy aspects of antiepileptic drugs in elderly versus younger patients with epilepsy: A pharmacoepidemiological study of CNS-active drugs in Norway, 2004-2015
   Epilepsy Res, 139, 35-42
   DOI 10.1016/j.eplepsyres.2017.11.001, PubMed 29175562
4. Baftiu A, Landmark CJ, Rusten IR, Feet SA, Johannessen SI, Larsson PG (2017)
   Erratum to: Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders-A pharmacoepidemiological study and clinical implications
   Eur J Clin Pharmacol, 73 (6), 791-792
   DOI 10.1007/s00228-017-2252-0, PubMed 28389679
5. Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS (2017)
   Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII)
   Epilepsia, 58 (2), 181-221
   DOI 10.1111/epi.13634, PubMed 28111749
6. Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS, Koepp MJ (2017)
   Seizure detection and neuromodulation: A summary of data presented at the XIII conference on new antiepileptic drug and devices (EILAT XIII)
   Epilepsy Res, 130, 27-36
   DOI 10.1016/j.eplepsyres.2017.01.004, PubMed 28113141
7. Bremer S, Vethe NT, Skauby M, Kasbo M, Johansson ED, Midtvedt K, Bergan S (2017)
   NFAT-regulated cytokine gene expression during tacrolimus therapy early after renal transplantation
   Br J Clin Pharmacol, 83 (11), 2494-2502
   DOI 10.1111/bcp.13367, PubMed 28686294
8. Burns ML, Lang AM (2017)
   The authors reply
   Pediatr Crit Care Med, 18 (1), 98
   DOI 10.1097/PCC.0000000000001023, PubMed 28060165
9. Eek AK, Øie E, Granas AG (2017)
   Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments
   Eur J Clin Pharmacol, 74 (3), 323-330
   DOI 10.1007/s00228-017-2374-4, PubMed 29149366
10. Egeland EJ, Robertsen I, Hermann M, Midtvedt K, Størset E, Gustavsen MT, Reisæter AV, Klaasen R, Bergan S, Holdaas H, Hartmann A, Åsberg A (2017)
    High Tacrolimus Clearance Is a Risk Factor for Acute Rejection in the Early Phase After Renal Transplantation
    Transplantation, 101 (8), e273-e279
    DOI 10.1097/TP.0000000000001796, PubMed 28452920
11. Føreid S, Gadeholt G (2017)
    Beta-hydroxybutyrate and pyroglutamate can be included in a rapid GC-MS screening method for differential diagnosis of metabolic acidosis
    Scand J Clin Lab Invest, 77 (2), 149-152
    DOI 10.1080/00365513.2016.1278261, PubMed 28150506
12. Havig SM, Høiseth G, Strand MC, Karinen RA, Brochmann GW, Strand DH, Bachs L, Vindenes V (2017)
    THC and CBD in blood samples and seizures in Norway: Does CBD affect THC-induced impairment in apprehended subjects?
    Forensic Sci Int, 276, 12-17
    DOI 10.1016/j.forsciint.2017.04.006, PubMed 28463706
13. Hjelmeland K, Gustavsen I, Øiestad EL, Øiestad ÅML, Høiseth G, Mørland J (2017)
    Zopiclone concentrations in oral fluid and blood after, administration of therapeutic doses of zopiclone
    Forensic Sci Int, 278, 177-183
    DOI 10.1016/j.forsciint.2017.07.004, PubMed 28735217
14. Høiseth G, Gottås A, Berg T, Arnestad M, Halvorsen PS, Bachs LC (2017)
    Urinary Kinetics of Heroin Metabolites in Pigs Shortly After Intake
    J Anal Toxicol, 41 (5), 451-454
    DOI 10.1093/jat/bkx017, PubMed 28335030
15. Jendresen C, Daws MR, Nilsson LNG (2017)
    An improved CPRG colorimetric ligand-receptor signal transduction assay based on beta-galactosidase activity in mammalian BWZ-reporter cells
    J Pharmacol Toxicol Methods, 90, 67-75
    DOI 10.1016/j.vascn.2017.11.004, PubMed 29203451
16. Jendresen C, Årskog V, Daws MR, Nilsson LN (2017)
    The Alzheimer's disease risk factors apolipoprotein E and TREM2 are linked in a receptor signaling pathway
    J Neuroinflammation, 14 (1), 59
    DOI 10.1186/s12974-017-0835-4, PubMed 28320424
17. Johannessen Landmark C, Burns ML, Baftiu A, Farmen AH, Lossius MI, Johannessen SI, Tomson T (2017)
    Pharmacokinetic variability of valproate in women of childbearing age
    Epilepsia, 58 (10), e142-e146
    DOI 10.1111/epi.13872, PubMed 28833045
18. Krogh N, Rzeppa S, Dyreborg A, Dehnes Y, Hemmersbach P, Backer V, Hostrup M (2017)
    Terbutaline Accumulates in Blood and Urine after Daily Therapeutic Inhalation
    Med Sci Sports Exerc, 49 (6), 1236-1243
    DOI 10.1249/MSS.0000000000001199, PubMed 28072631
19. Meier S, Andressen KW, Aronsen JM, Sjaastad I, Hougen K, Skomedal T, Osnes JB, Qvigstad E, Levy FO, Moltzau LR (2017)
    PDE3 inhibition by C-type natriuretic peptide-induced cGMP enhances cAMP-mediated signaling in both non-failing and failing hearts
    Eur J Pharmacol, 812, 174-183
    DOI 10.1016/j.ejphar.2017.07.014, PubMed 28697992
20. Midtvedt K, Bergan S, Reisæter AV, Vikse BE, Åsberg A (2017)
    Exposure to Mycophenolate and Fatherhood
    Transplantation, 101 (7), e214-e217
    DOI 10.1097/TP.0000000000001747, PubMed 28346297
21. Midtvedt K, Holdaas H, Bergan S, Åsberg A (2017)
    Costimulation Blockade: America First, Canada Second … What About Norway?
    Am J Transplant, 17 (8), 2230
    DOI 10.1111/ajt.14351, PubMed 28508535
22. Pisani LR, Nikanorova M, Landmark CJ, Johannessen SI, Pisani F (2017)
    Specific Patient Features Affect Antiepileptic Drug Therapy Decisions: Focus on Gender, Age, and Psychiatric Comorbidities
    Curr Pharm Des, 23 (37), 5639-5648
    DOI 10.2174/1381612823666170926103631, PubMed 28950817
23. Pitarch-Motellón J, Roig-Navarro AF, Sancho JV, Ibáñez M, Fabregat-Cabello N, Pozo OJ, Ventura R, García Alonso JI, Rodríguez-González P, González Gago A, Ereño Artabe A, Van Eenoo P, Deventer K, Dehnes Y, Rzeppa S (2017)
    Evaluation of uncertainty sources in the determination of testosterone in urine by calibration-based and isotope dilution quantification using ultra high performance liquid chromatography tandem mass spectrometry
    J Chromatogr A, 1508, 73-80
    DOI 10.1016/j.chroma.2017.05.072, PubMed 28601363
24. Raeder J, Dahl V, Markestad A, Nordbo A, Roaldset AH, Stubhaug A, Soeberg B, Willke A, Aasbo V, Johansen PW (2017)
    From ketobemidone to morphine or oxycodone
    Tidsskr. Nor. Laegeforen., 137 (3), 170
25. Reimers A, Berg JA, Burns ML, Landmark CJ (2017)
    Common reference range for antiepileptics
    Tidsskr. Nor. Laegeforen., 137 (12-13), 864-865
26. Reimers A, Berg JA, Burns ML, Landmark CJ (2017)
    Harmonised reference ranges for antiepileptic drugs
    Tidsskr Nor Laegeforen, 137 (12-13), 864-865
    DOI 10.4045/tidsskr.17.0392, PubMed 28655236
27. Salvador CL, Hartmann A, Åsberg A, Bergan S, Rowe AD, Mørkrid L (2017)
    Estimating Glomerular Filtration Rate in Kidney Transplant Recipients: Comparing a Novel Equation With Commonly Used Equations in this Population
    Transplant Direct, 3 (12), e332
    DOI 10.1097/TXD.0000000000000742, PubMed 29536033
28. Skauby RH, Bjerre A, Sæves I, Vethe NT, Bremer S, Svarstad A, Bergan S (2017)
    Prednisolone and Prednisone Pharmacokinetics in Pediatric Renal Transplant Recipients-A Prospective Study
    Ther Drug Monit, 39 (5), 472-482
    DOI 10.1097/FTD.0000000000000439, PubMed 28749817
29. Strand TE, Khiabani HZ, Boico A, Radiloff D, Zhao Y, Hamilton KL, Christians U, Klawitter J, Noveck RJ, Piantadosi CA, Bell C, Irwin D, Schroeder T (2017)
    The novel combination of theophylline and bambuterol as a potential treatment of hypoxemia in humans
    Can J Physiol Pharmacol, 95 (9), 1009-1018
    DOI 10.1139/cjpp-2016-0635, PubMed 28467859
30. Størset E, Hole K, Midtvedt K, Bergan S, Molden E, Åsberg A (2017)
    The CYP3A biomarker 4β-hydroxycholesterol does not improve tacrolimus dose predictions early after kidney transplantation
    Br J Clin Pharmacol, 83 (7), 1457-1465
    DOI 10.1111/bcp.13248, PubMed 28146606
31. Størset E, Hole K, Midtvedt K, Bergan S, Molden E, Åsberg A (2017)
    Response to: 'Response to: Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'
    Br J Clin Pharmacol, 83 (6), 1357-1358
    DOI 10.1111/bcp.13276, PubMed 28374426
32. Svendsen T, Brodtkorb E, Baftiu A, Burns ML, Johannessen SI, Johannessen Landmark C (2017)
    Therapeutic Drug Monitoring of Lacosamide in Norway: Focus on Pharmacokinetic Variability, Efficacy and Tolerability
    Neurochem Res, 42 (7), 2077-2083
    DOI 10.1007/s11064-017-2234-8, PubMed 28349359
33. Torp HA, Gustavsen I, Romundstad L (2017)
    [A botanical anesthesia]
    Tidsskr Nor Laegeforen, 137 (23-24)
    DOI 10.4045/tidsskr.17.0659, PubMed 29231661
34. Torp HA, Gustavsen I, Romundstad L (2017)
    A botanical anesthesia
    Tidsskr. Nor. Laegeforen., 137 (23-24), 1924-1928
35. Westergren T, Debernard KA (2017)
    Discrepancies in paper by Chiam et al.: The haemodynamic effects of intravenous paracetamol
    Br J Clin Pharmacol, 83 (2), 435
    DOI 10.1111/bcp.13182, PubMed 28090696
36. Westergren T, Narum S, Klemp M (2017)
    Characterization of gastrointestinal adverse effects reported in clinical studies of corticosteroid therapy
    J Clin Epidemiol, 94, 19-26
    DOI 10.1016/j.jclinepi.2017.10.018, PubMed 29113937
37. Ødegård J, Sondresen JE, Aasrum M, Tveteraas IH, Guren TK, Christoffersen T, Thoresen GH (2017)
    Differential effects of epidermal growth factor (EGF) receptor ligands on receptor binding, downstream signalling pathways and DNA synthesis in hepatocytes
    Growth Factors, 35 (6), 239-248
    DOI 10.1080/08977194.2018.1453506, PubMed 29582692

Publications 2016

1. Baftiu A, Johannessen Landmark C, Rusten IR, Feet SA, Johannessen SI, Larsson PG (2016)
   Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders-a pharmacoepidemiological study and clinical implications
   Eur J Clin Pharmacol, 72 (10), 1245-1254
   DOI 10.1007/s00228-016-2092-3, PubMed 27411937
2. Bjørnebekk A, Walhovd KB, Jørstad ML, Due-Tønnessen P, Hullstein IR, Fjell AM (2016)
   Structural Brain Imaging of Long-Term Anabolic-Androgenic Steroid Users and Nonusing Weightlifters
   Biol Psychiatry, 82 (4), 294-302
   DOI 10.1016/j.biopsych.2016.06.017, PubMed 27616036
3. Brunet M, Shipkova M, van Gelder T, Wieland E, Sommerer C, Budde K, Haufroid V, Christians U, López-Hoyos M, Barten MJ, Bergan S, Picard N, Millán López O, Marquet P, Hesselink DA, Noceti O, Pawinski T, Wallemacq P, Oellerich M (2016)
   Barcelona Consensus on Biomarker-Based Immunosuppressive Drugs Management in Solid Organ Transplantation
   Ther Drug Monit, 38 Suppl 1, S1-20
   DOI 10.1097/FTD.0000000000000287, PubMed 26977997
4. Braadland PR, Grytli HH, Ramberg H, Katz B, Kellman R, Gauthier-Landry L, Fazli L, Krobert KA, Wang W, Levy FO, Bjartell A, Berge V, Rennie PS, Mellgren G, Mælandsmo GM, Svindland A, Barbier O, Taskén KA (2016)
   Low β₂-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism
   Oncotarget, 7 (2), 1878-94
   DOI 10.18632/oncotarget.6479, PubMed 26646591
5. Burns ML, Baftiu A, Opdal MS, Johannessen SI, Landmark CJ (2016)
   Therapeutic Drug Monitoring of Clobazam and Its Metabolite-Impact of Age and Comedication on Pharmacokinetic Variability
   Ther Drug Monit, 38 (3), 350-7
   DOI 10.1097/FTD.0000000000000272, PubMed 26751267
6. Burns ML, Stensvold HJ, Risnes K, Guthe HJ, Astrup H, Nordhov SM, Selberg TR, Rønnestad A, Lang AM, Norwegian Neonatal Network (2016)
   Inotropic Therapy in Newborns, A Population-Based National Registry Study
   Pediatr Crit Care Med, 17 (10), 948-956
   DOI 10.1097/PCC.0000000000000898, PubMed 27500723
7. Damkier P, Passier A, Bo Petersen L, Havnen G, Thestrup Pedersen AJ (2016)
   Changing of the guards: EMA warning on paternal use of mycophenolate mofetil: An unnecessary and insufficiently substantiated precaution
   Birth Defects Res A Clin Mol Teratol, 106 (10), 860-861
   DOI 10.1002/bdra.23556, PubMed 27678452
8. Dyreborg A, Krogh N, Backer V, Rzeppa S, Hemmersbach P, Hostrup M (2016)
   Pharmacokinetics of Oral and Inhaled Terbutaline after Exercise in Trained Men
   Front Pharmacol, 7, 150
   DOI 10.3389/fphar.2016.00150, PubMed 27375484
9. Eikemo H, Moltzau LR, Hussain RI, Nguyen CH, Qvigstad E, Levy FO, Skomedal T, Osnes JB (2016)
   CaMKII in addition to MLCK contributes to phosphorylation of regulatory light chain in cardiomyocytes
   Biochem Biophys Res Commun, 471 (1), 219-25
   DOI 10.1016/j.bbrc.2016.01.132, PubMed 26809094
10. Eikemo H, Moltzau LR, Nguyen CHT, Levy FO, Skomedal T, Osnes JB (2016)
    CaMKII and at least two unidentified kinases phosphorylate regulatory light chain in non-contracting cardiomyocytes
    Biochem Biophys Res Commun, 477 (1), 14-19
    DOI 10.1016/j.bbrc.2016.05.138, PubMed 27237977
11. Gottås A, Arnestad M, Halvorsen PS, Bachs LC, Høiseth G (2016)
    Pharmacokinetics of heroin and its metabolites in vitreous humor and blood in a living pig model
    Forensic Toxicol, 34 (2), 277-285
    DOI 10.1007/s11419-016-0315-z, PubMed 27660664
12. Haga C, Opdal MS, Tuv SS, Zahl PH, Stenberg-Nilsen H (2016)
    [Drug safety associated with the change of digitalis drug in Norway]
    Tidsskr Nor Laegeforen, 136 (20), 1714-1718
    DOI 10.4045/tidsskr.15.0161, PubMed 27830905
13. Halden TA, Egeland EJ, Åsberg A, Hartmann A, Midtvedt K, Khiabani HZ, Holst JJ, Knop FK, Hornum M, Feldt-Rasmussen B, Jenssen T (2016)
    GLP-1 Restores Altered Insulin and Glucagon Secretion in Posttransplantation Diabetes
    Diabetes Care, 39 (4), 617-24
    DOI 10.2337/dc15-2383, PubMed 26908914
14. Heitmann K, Havnen GC, Holst L, Nordeng H (2016)
    Pregnancy outcomes after prenatal exposure to echinacea: the Norwegian Mother and Child Cohort Study
    Eur J Clin Pharmacol, 72 (5), 623-30
    DOI 10.1007/s00228-016-2021-5, PubMed 26895223
15. Heitmann K, Solheimsnes A, Havnen GC, Nordeng H, Holst L (2016)
    Treatment of nausea and vomiting during pregnancy -a cross-sectional study among 712 Norwegian women
    Eur J Clin Pharmacol, 72 (5), 593-604
    DOI 10.1007/s00228-016-2012-6, PubMed 26815908
16. Helland A, Berg JA, Gustavsen I, Nordal K, Hilberg T, Aronsen L, Arnestad M, Narum S (2016)
    Serum concentration measurements of addictive drugs
    Tidsskr Nor Laegeforen, 136 (5), 400-2
    DOI 10.4045/tidsskr.16.0030, PubMed 26983140
17. Henjum K, Almdahl IS, Årskog V, Minthon L, Hansson O, Fladby T, Nilsson LN (2016)
    Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease
    Alzheimers Res Ther, 8 (1), 17
    DOI 10.1186/s13195-016-0182-1, PubMed 27121148
18. Johannessen Landmark C, Henning O, Johannessen SI (2016)
    Proconvulsant effects of antidepressants - What is the current evidence?
    Epilepsy Behav, 61, 287-291
    DOI 10.1016/j.yebeh.2016.01.029, PubMed 26926001
19. Johannessen Landmark C, Svendsen T, Dinarevic J, Kufaas RF, Reimers A, Brodtkorb E, Baftiu A, Burns ML, Johannessen SI (2016)
    The Impact of Pharmacokinetic Interactions With Eslicarbazepine Acetate Versus Oxcarbazepine and Carbamazepine in Clinical Practice
    Ther Drug Monit, 38 (4), 499-505
    DOI 10.1097/FTD.0000000000000306, PubMed 27414974
20. Kloster-Jensen K, Sahraoui A, Vethe NT, Korsgren O, Bergan S, Foss A, Scholz H (2016)
    Treatment with Tacrolimus and Sirolimus Reveals No Additional Adverse Effects on Human Islets In Vitro Compared to Each Drug Alone but They Are Reduced by Adding Glucocorticoids
    J Diabetes Res, 2016, 4196460
    DOI 10.1155/2016/4196460, PubMed 26885529
21. Kong XY, Feng YZ, Eftestøl E, Kase ET, Haugum H, Eskild W, Rustan AC, Thoresen GH (2016)
    Increased glucose utilization and decreased fatty acid metabolism in myotubes from Glmp(gt/gt) mice
    Arch Physiol Biochem, 122 (1), 36-45
    DOI 10.3109/13813455.2015.1120752, PubMed 26707125
22. Kreiberg M, Becker V, Jessen S, Rzeppa S, Hemmersbach P, Backer V, Hostrup M (2016)
    Influence of exercise in normal and hot ambient conditions on the pharmacokinetics of inhaled terbutaline in trained men
    Scand J Med Sci Sports, 27 (7), 692-703
    DOI 10.1111/sms.12697, PubMed 27167471
23. Krogh N, Backer V, Rzeppa S, Hemmersbach P, Hostrup M (2016)
    Pharmacokinetics of nebulized and oral procaterol in asthmatic and non-asthmatic subjects in relation to doping analysis
    Drug Test Anal, 8 (10), 1056-1064
    DOI 10.1002/dta.1935, PubMed 26990656
24. Landmark CJ, Johannessen SI, Tomson T (2016)
    Dosing strategies for antiepileptic drugs: from a standard dose for all to individualised treatment by implementation of therapeutic drug monitoring
    Epileptic Disord, 18 (4), 367-383
    DOI 10.1684/epd.2016.0880, PubMed 27965183
25. Lund J, Stensrud C, Rajender, Bohov P, Thoresen GH, Berge RK, Wright M, Kamal A, Rustan AC, Miller AD, Skorve J (2016)
    The molecular structure of thio-ether fatty acids influences PPAR-dependent regulation of lipid metabolism
    Bioorg Med Chem, 24 (6), 1191-203
    DOI 10.1016/j.bmc.2016.01.045, PubMed 26874397
26. Mevaag M, Henning O, Baftiu A, Granas AG, Johannessen SI, Nakken KO, Johannessen Landmark C (2016)
    Discrepancies between physicians' prescriptions and patients' use of antiepileptic drugs
    Acta Neurol Scand, 135 (1), 80-87
    DOI 10.1111/ane.12578, PubMed 26923477
27. Moen B, Henjum K, Måge I, Knutsen SH, Rud I, Hetland RB, Paulsen JE (2016)
    Effect of Dietary Fibers on Cecal Microbiota and Intestinal Tumorigenesis in Azoxymethane Treated A/J Min/+ Mice
    PLoS One, 11 (5), e0155402
    DOI 10.1371/journal.pone.0155402, PubMed 27196124
28. Narum S, Brørs O, Stokland O, Kringen MK (2016)
    Mortality among head trauma patients taking preinjury antithrombotic agents: a retrospective cohort analysis from a Level 1 trauma centre
    BMC Emerg Med, 16 (1), 29
    DOI 10.1186/s12873-016-0094-1, PubMed 27485307
29. Norum HM, Kolberg ES, Solhaug V, Nordal K, Aukrust P (2016)
    Rhabdomyolysis and capillary leak syndrome in a patient treated with topical imiquimod
    Int J Dermatol, 55 (9), 1030-2
    DOI 10.1111/ijd.13255, PubMed 27061736
30. Olberg DE, Bauer N, Andressen KW, Hjørnevik T, Cumming P, Levy FO, Klaveness J, Haraldsen I, Sutcliffe JL (2016)
    Brain penetrant small molecule (18)F-GnRH receptor (GnRH-R) antagonists: Synthesis and preliminary positron emission tomography imaging in rats
    Nucl Med Biol, 43 (8), 478-89
    DOI 10.1016/j.nucmedbio.2016.05.003, PubMed 27236283
31. Picard N, Bergan S, Marquet P, van Gelder T, Wallemacq P, Hesselink DA, Haufroid V (2016)
    Pharmacogenetic Biomarkers Predictive of the Pharmacokinetics and Pharmacodynamics of Immunosuppressive Drugs
    Ther Drug Monit, 38 Suppl 1, S57-69
    DOI 10.1097/FTD.0000000000000255, PubMed 26469711
32. Rzeppa S, Viet L (2016)
    Analysis of sulfate metabolites of the doping agents oxandrolone and danazol using high performance liquid chromatography coupled to tandem mass spectrometry
    J Chromatogr B Analyt Technol Biomed Life Sci, 1029-1030, 1-9
    DOI 10.1016/j.jchromb.2016.06.028, PubMed 27394004
33. Rzeppa S, Viet LN (2016)
    Analysis of tolvaptan and its metabolites in sports drug testing by high-performance liquid chromatography coupled to tandem mass spectrometry
    Drug Test Anal, 8 (10), 1090-1094
    DOI 10.1002/dta.1933, PubMed 26768215
34. Sakshaug S, Handal M, Hjellvik V, Berg C, Ripel Å, Gustavsen I, Mørland J, Skurtveit S (2016)
    Long-term Use of Z-Hypnotics and Co-medication with Benzodiazepines and Opioids
    Basic Clin Pharmacol Toxicol, 120 (3), 292-298
    DOI 10.1111/bcpt.12684, PubMed 27717229
35. Størset E, Hole K, Midtvedt K, Bergan S, Molden E, Åsberg A (2016)
    Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance
    Br J Clin Pharmacol, 83 (6), 1350-1352
    DOI 10.1111/bcp.13188, PubMed 28008657
36. Størset E, von Düring ME, Godang K, Bergan S, Midtvedt K, Åsberg A (2016)
    Prediction of Fat-Free Mass in Kidney Transplant Recipients
    Ther Drug Monit, 38 (4), 439-46
    DOI 10.1097/FTD.0000000000000305, PubMed 27019101
37. Størset E, Åsberg A, Hartmann A, Reisaeter AV, Holdaas H, Skauby M, Bergan S, Midtvedt K (2016)
    Low-target tacrolimus in de novo standard risk renal transplant recipients: A single-centre experience
    Nephrology (Carlton), 21 (10), 821-7
    DOI 10.1111/nep.12738, PubMed 26854648
38. Svendsen T, Brodtkorb E, Reimers A, Molden E, Sætre E, Johannessen SI, Johannessen Landmark C (2016)
    Pharmacokinetic variability, efficacy and tolerability of eslicarbazepine acetate-A national approach to the evaluation of therapeutic drug monitoring data and clinical outcome
    Epilepsy Res, 129, 125-131
    DOI 10.1016/j.eplepsyres.2016.12.001, PubMed 28043062
39. Tekpli X, Urbanucci A, Hashim A, Vågbø CB, Lyle R, Kringen MK, Staff AC, Dybedal I, Mills IG, Klungland A, Staerk J (2016)
    Changes of 5-hydroxymethylcytosine distribution during myeloid and lymphoid differentiation of CD34+ cells
    Epigenetics Chromatin, 9, 21
    DOI 10.1186/s13072-016-0070-8, PubMed 27252783
40. Tuv SS, Krabseth HM, Strand MC, Karinen RA, Wiik E, Vevelstad MS, Westin AA, Øiestad EL, Vindenes V (2016)
    New designer drugs from the web
    Tidsskr Nor Laegeforen, 136 (8), 721-3
    DOI 10.4045/tidsskr.15.1276, PubMed 27143463
41. Villar IC, Bubb KJ, Moyes AJ, Steiness E, Gulbrandsen T, Levy FO, Hobbs AJ (2016)
    Functional pharmacological characterization of SER100 in cardiovascular health and disease
    Br J Pharmacol, 173 (23), 3386-3401
    DOI 10.1111/bph.13634, PubMed 27667485
42. Westlye LT, Kaufmann T, Alnæs D, Hullstein IR, Bjørnebekk A (2016)
    Brain connectivity aberrations in anabolic-androgenic steroid users
    Neuroimage Clin, 13, 62-69
    DOI 10.1016/j.nicl.2016.11.014, PubMed 27942448
43. Aasrum M, Brusevold IJ, Christoffersen T, Thoresen GH (2016)
    HGF-induced DNA synthesis in hepatocytes is suppressed by p38
    Growth Factors, 34 (5-6), 217-223
    DOI 10.1080/08977194.2017.1285765, PubMed 28209091
44. Åstrand OAH, Viktorsson EÖ, Kristensen AL, Ekeberg D, Røberg-Larsen H, Wilson SR, Gabrielsen M, Sylte I, Rustan AC, Thoresen GH, Rongved P, Kase ET (2016)
    Synthesis, in vitro and in vivo biological evaluation of new oxysterols as modulators of the liver X receptors
    J Steroid Biochem Mol Biol, 165 (Pt B), 323-330
    DOI 10.1016/j.jsbmb.2016.07.010, PubMed 27471149

Publications 2015

1. Baftiu A, Johannessen Landmark C, Nikaj V, Neslein IL, Johannessen SI, Perucca E (2015)
   Availability of antiepileptic drugs across Europe
   Epilepsia, 56 (12), e191-7
   DOI 10.1111/epi.13210, PubMed 26477534
2. Bakke SS, Feng YZ, Nikolić N, Kase ET, Moro C, Stensrud C, Damlien L, Ludahl MO, Sandbu R, Solheim BM, Rustan AC, Hjelmesæth J, Thoresen GH, Aas V (2015)
   Myotubes from severely obese type 2 diabetic subjects accumulate less lipids and show higher lipolytic rate than myotubes from severely obese non-diabetic subjects
   PLoS One, 10 (3), e0119556
   DOI 10.1371/journal.pone.0119556, PubMed 25790476
3. Beiske GA, Holmøy T, Beiske AG, Johannessen SI, Johannessen Landmark C (2015)
   Antiepileptic and Antidepressive Polypharmacy in Patients with Multiple Sclerosis
   Mult Scler Int, 2015, 317859
   DOI 10.1155/2015/317859, PubMed 26221541
4. Bergan S, Bremer S, Vethe NT (2015)
   Drug target molecules to guide immunosuppression
   Clin Biochem, 49 (4-5), 411-8
   DOI 10.1016/j.clinbiochem.2015.10.001, PubMed 26453533
5. Bernard JP, Khiabani HZ, Hilberg T, Karinen R, Slørdal L, Waal H, Mørland J (2015)
   Characteristics of methadone-related fatalities in Norway
   J Forensic Leg Med, 36, 114-20
   DOI 10.1016/j.jflm.2015.09.011, PubMed 26439870
6. Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS (2015)
   Progress report on new antiepileptic drugs: A summary of the Twelfth Eilat Conference (EILAT XII)
   Epilepsy Res, 111, 85-141
   DOI 10.1016/j.eplepsyres.2015.01.001, PubMed 25769377
7. Bjørner T, Anwar T, Brede WR, Hemmersbach P, Slørdal L (2015)
   [A man with a changed appearance]
   Tidsskr Nor Laegeforen, 135 (3), 243-5
   DOI 10.4045/tidsskr.14.0886, PubMed 25668542
8. Bremer S, Fløisand Y, Brinch L, Gedde-Dahl T, Bergan S (2015)
   Glutathione Transferase Gene Variants Influence Busulfan Pharmacokinetics and Outcome After Myeloablative Conditioning
   Ther Drug Monit, 37 (4), 493-500
   DOI 10.1097/FTD.0000000000000180, PubMed 25565670
9. Cehajic I, Bergan S, Bjordal K (2015)
   Pharmacist assessment of drug-related problems on an oncology ward
   Eur. J. Hosp. Pharm.-Sci. Pract., 22 (4), 194-197
10. de Graav GN, Bergan S, Baan CC, Weimar W, van Gelder T, Hesselink DA (2015)
    Therapeutic Drug Monitoring of Belatacept in Kidney Transplantation
    Ther Drug Monit, 37 (5), 560-7
    DOI 10.1097/FTD.0000000000000179, PubMed 25551406
11. Fagermoen E, Sulheim D, Winger A, Andersen AM, Gjerstad J, Godang K, Rowe PC, Saul JP, Skovlund E, Wyller VB (2015)
    Effects of low-dose clonidine on cardiovascular and autonomic variables in adolescents with chronic fatigue: a randomized controlled trial
    BMC Pediatr, 15, 117
    DOI 10.1186/s12887-015-0428-2, PubMed 26357864
12. Feng YZ, Nikolić N, Bakke SS, Kase ET, Guderud K, Hjelmesæth J, Aas V, Rustan AC, Thoresen GH (2015)
    Myotubes from lean and severely obese subjects with and without type 2 diabetes respond differently to an in vitro model of exercise
    Am J Physiol Cell Physiol, 308 (7), C548-56
    DOI 10.1152/ajpcell.00314.2014, PubMed 25608533
13. Hjelmeland K, Gustavsen I, Bernard JP, Mørland J (2015)
    Can a simple clinical test detect impairment of zopiclone and alcohol? - A randomized controlled trial
    Forensic Sci Int, 248, 129-33
    DOI 10.1016/j.forsciint.2014.12.028, PubMed 25617762
14. Hovda KE, Gadeholt G, Evtodienko V, Jacobsen D (2015)
    A novel bedside diagnostic test for methanol poisoning using dry chemistry for formate
    Scand J Clin Lab Invest, 75 (7), 610-4
    DOI 10.3109/00365513.2015.1066847, PubMed 26203958
15. Hullstein IR, Malerod-Fjeld H, Dehnes Y, Hemmersbach P (2015)
    Black market products confiscated in Norway 2011-2014 compared to analytical findings in urine samples
    Drug Test Anal, 7 (11-12), 1025-9
    DOI 10.1002/dta.1900, PubMed 26607218
16. Haase CB, Backer V, Kalsen A, Rzeppa S, Hemmersbach P, Hostrup M (2015)
    The influence of exercise and dehydration on the urine concentrations of salbutamol after inhaled administration of 1600 µg salbutamol as a single dose in relation to doping analysis
    Drug Test Anal, 8 (7), 613-20
    DOI 10.1002/dta.1828, PubMed 26044066
17. Impellizzeri AA, Pappalardo M, Basile L, Manfra O, Andressen KW, Krobert KA, Messina A, Levy FO, Guccione S (2015)
    Identification of essential residues for binding and activation in the human 5-HT7(a) serotonin receptor by molecular modeling and site-directed mutagenesis
    Front Behav Neurosci, 9, 92
    DOI 10.3389/fnbeh.2015.00092, PubMed 26005408
18. Jabeen S, Holmboe L, Alnæs GI, Andersen AM, Hall KS, Kristensen VN (2015)
    Impact of genetic variants of RFC1, DHFR and MTHFR in osteosarcoma patients treated with high-dose methotrexate
    Pharmacogenomics J, 15 (5), 385-90
    DOI 10.1038/tpj.2015.11, PubMed 25778468
19. Johannessen Landmark C, Beiske G, Baftiu A, Burns ML, Johannessen SI (2015)
    Experience from therapeutic drug monitoring and gender aspects of gabapentin and pregabalin in clinical practice
    Seizure, 28, 88-91
    DOI 10.1016/j.seizure.2015.02.017, PubMed 25758302
20. Johannessen Landmark C, I Johannessen S (2015)
    Pharmacotherapy in epilepsy - does gender affect safety?
    Expert Opin Drug Saf, 15 (1), 1-4
    DOI 10.1517/14740338.2016.1117606, PubMed 26650146
21. Karlsen Bjånes T, Mjåset Hjertø E, Lønne L, Aronsen L, Andsnes Berg J, Bergan S, Otto Berg-Hansen G, Bernard JP, Larsen Burns M, Toralf Fosen J, Frost J, Hilberg T, Krabseth HM, Kvan E, Narum S, Austgulen Westin A (2015)
    Pharmacology Portal: An Open Database for Clinical Pharmacologic Laboratory Services
    Clin Ther, 38 (1), 222-6
    DOI 10.1016/j.clinthera.2015.10.015, PubMed 26546404
22. Kase ET, Feng YZ, Badin PM, Bakke SS, Laurens C, Coue M, Langin D, Gaster M, Thoresen GH, Rustan AC, Moro C (2015)
    Primary defects in lipolysis and insulin action in skeletal muscle cells from type 2 diabetic individuals
    Biochim Biophys Acta, 1851 (9), 1194-201
    DOI 10.1016/j.bbalip.2015.03.005, PubMed 25819461
23. Kaupang Å, Paulsen SM, Steindal CC, Ravna AW, Sylte I, Halvorsen TG, Thoresen GH, Hansen TV (2015)
    Synthesis, biological evaluation and molecular modeling studies of the PPARβ/δ antagonist CC618
    Eur J Med Chem, 94, 229-36
    DOI 10.1016/j.ejmech.2015.03.006, PubMed 25768705
24. Kloster-Jensen K, Vethe NT, Bremer S, Abadpour S, Korsgren O, Foss A, Bergan S, Scholz H (2015)
    Intracellular sirolimus concentration is reduced by tacrolimus in human pancreatic islets in vitro
    Transpl Int, 28 (10), 1152-61
    DOI 10.1111/tri.12617, PubMed 26046470
25. Kong XY, Kase ET, Herskedal A, Schjalm C, Damme M, Nesset CK, Thoresen GH, Rustan AC, Eskild W (2015)
    Lack of the Lysosomal Membrane Protein, GLMP, in Mice Results in Metabolic Dysregulation in Liver
    PLoS One, 10 (6), e0129402
    DOI 10.1371/journal.pone.0129402, PubMed 26047317
26. Kringen MK (2015)
    Analysis of Copy Number Variation by Pyrosequencing® Using Paralogous Sequences
    Methods Mol Biol, 1315, 115-21
    DOI 10.1007/978-1-4939-2715-9_9, PubMed 26103895
27. Kringen MK, Stormo C, Berg JP, Terry SF, Vocke CM, Rizvi S, Hendig D, Piehler AP (2015)
    Copy number variation in the ATP-binding cassette transporter ABCC6 gene and ABCC6 pseudogenes in patients with pseudoxanthoma elasticum
    Mol Genet Genomic Med, 3 (3), 233-7
    DOI 10.1002/mgg3.137, PubMed 26029710
28. Manfra O, Van Craenenbroeck K, Skieterska K, Frimurer T, Schwartz TW, Levy FO, Andressen KW (2015)
    Downregulation of 5-HT7 Serotonin Receptors by the Atypical Antipsychotics Clozapine and Olanzapine. Role of Motifs in the C-Terminal Domain and Interaction with GASP-1
    ACS Chem Neurosci, 6 (7), 1206-18
    DOI 10.1021/cn500339p, PubMed 25706089
29. Nordal K, Øiestad EL, Enger A, Christophersen AS, Vindenes V (2015)
    Detection Times of Diazepam, Clonazepam, and Alprazolam in Oral Fluid Collected From Patients Admitted to Detoxification, After High and Repeated Drug Intake
    Ther Drug Monit, 37 (4), 451-60
    DOI 10.1097/FTD.0000000000000174, PubMed 25549207
30. Olberg DE, Hausner SH, Bauer N, Klaveness J, Indrevoll B, Andressen KW, Dahl M, Levy FO, Sutcliffe JL, Haraldsen I (2015)
    Radiosynthesis of high affinity fluorine-18 labeled GnRH peptide analogues: in vitro studies and in vivo assessment of brain uptake in rats
    MedChemComm, 6 (4), 708-714
31. Opdal MS, Arnesen M, Müller LD, Hullstein I, Sayed K, Brørs O, Kringen M, Sagedal S, Gjesdal K, Krajci P (2015)
    Effects of Hemodialysis on Methadone Pharmacokinetics and QTc
    Clin Ther, 37 (7), 1594-9
    DOI 10.1016/j.clinthera.2015.04.009, PubMed 25963997
32. Reiter L, Westergren T (2015)
    Emergency contraception in overweight - to trust?
    Tidsskr. Nor. Laegeforen., 135 (18), 1629-1630
33. Robertsen I, Vethe NT, Midtvedt K, Falck P, Christensen H, Åsberg A (2015)
    Closer to the Site of Action: Everolimus Concentrations in Peripheral Blood Mononuclear Cells Correlate Well With Whole Blood Concentrations
    Ther Drug Monit, 37 (5), 675-80
    DOI 10.1097/FTD.0000000000000185, PubMed 25565673
34. Robertsen I, Åsberg A, Ingerø AO, Vethe NT, Bremer S, Bergan S, Midtvedt K (2015)
    Use of generic tacrolimus in elderly renal transplant recipients: precaution is needed
    Transplantation, 99 (3), 528-32
    DOI 10.1097/TP.0000000000000384, PubMed 25148382
35. Rogeberg M, Almdahl IS, Wettergreen M, Nilsson LN, Fladby T (2015)
    Isobaric Quantification of Cerebrospinal Fluid Amyloid-β Peptides in Alzheimer's Disease: C-Terminal Truncation Relates to Early Measures of Neurodegeneration
    J Proteome Res, 14 (11), 4834-43
    DOI 10.1021/acs.jproteome.5b00668, PubMed 26452689
36. Rogeberg M, Wettergreen M, Nilsson LN, Fladby T (2015)
    Identification of amyloid beta mid-domain fragments in human cerebrospinal fluid
    Biochimie, 113, 86-92
    DOI 10.1016/j.biochi.2015.03.022, PubMed 25866191
37. Rzeppa S, Heinrich G, Hemmersbach P (2015)
    Analysis of anabolic androgenic steroids as sulfate conjugates using high performance liquid chromatography coupled to tandem mass spectrometry
    Drug Test Anal, 7 (11-12), 1030-9
    DOI 10.1002/dta.1895, PubMed 26472592
38. Salvador CL, Tøndel C, Mørkrid L, Bjerre A, Brun A, Bolann B, Brackman D, Bergan S (2015)
    Glomerular filtration rate measured by iohexol clearance: A comparison of venous samples and capillary blood spots
    Scand J Clin Lab Invest, 75 (8), 710-6
    DOI 10.3109/00365513.2015.1091091, PubMed 26426851
39. Størset E, Åsberg A, Skauby M, Neely M, Bergan S, Bremer S, Midtvedt K (2015)
    Improved Tacrolimus Target Concentration Achievement Using Computerized Dosing in Renal Transplant Recipients--A Prospective, Randomized Study
    Transplantation, 99 (10), 2158-66
    DOI 10.1097/TP.0000000000000708, PubMed 25886918
40. Tveteraas IH, Aasrum M, Brusevold IJ, Ødegård J, Christoffersen T, Sandnes D (2015)
    Lysophosphatidic acid induces both EGFR-dependent and EGFR-independent effects on DNA synthesis and migration in pancreatic and colorectal carcinoma cells
    Tumour Biol, 37 (2), 2519-26
    DOI 10.1007/s13277-015-4010-1, PubMed 26386720
41. Ørstavik Ø, Manfra O, Andressen KW, Andersen GØ, Skomedal T, Osnes JB, Levy FO, Krobert KA (2015)
    The inotropic effect of the active metabolite of levosimendan, OR-1896, is mediated through inhibition of PDE3 in rat ventricular myocardium
    PLoS One, 10 (3), e0115547
    DOI 10.1371/journal.pone.0115547, PubMed 25738589
42. Aasrum M, Tjomsland V, Thoresen GH, De Angelis PM, Christoffersen T, Brusevold IJ (2015)
    PI3K is required for both basal and LPA-induced DNA synthesis in oral carcinoma cells
    J Oral Pathol Med, 45 (6), 425-32
    DOI 10.1111/jop.12384, PubMed 26602326
43. Aasrum M, Ødegård J, Thoresen GH, Brusevold IJ, Sandnes DL, Christoffersen T (2015)
    Gab1 amplifies signaling in response to low-intensity stimulation by HGF
    Cell Biol Int, 39 (10), 1177-84
    DOI 10.1002/cbin.10511, PubMed 26146811

Publications 2014

1. Brudeli B, Navaratnarajah M, Andressen KW, Manfra O, Moltzau LR, Nilsen NO, Levy FO, Klaveness J (2014)
   Discovery and pharmacological profile of new hydrophilic 5-HT(4) receptor antagonists
   Bioorg Med Chem Lett, 24 (18), 4598-4602
   DOI 10.1016/j.bmcl.2014.06.083, PubMed 25149506
2. Brusevold IJ, Tveteraas IH, Aasrum M, Ødegård J, Sandnes DL, Christoffersen T (2014)
   Role of LPAR3, PKC and EGFR in LPA-induced cell migration in oral squamous carcinoma cells
   BMC Cancer, 14, 432
   DOI 10.1186/1471-2407-14-432, PubMed 24928086
3. Dehnes Y, Myrvold L, Ström H, Ericsson M, Hemmersbach P (2014)
   MAIIA EPO SeLect-a rapid screening kit for the detection of recombinant EPO analogues in doping control: inter-laboratory prevalidation and normative study of athlete urine and plasma samples
   Drug Test Anal, 6 (11-12), 1144-50
   DOI 10.1002/dta.1752, PubMed 25421537
4. Haug JB, Berild D, Walberg M, Reikvam Å (2014)
   Hospital- and patient-related factors associated with differences in hospital antibiotic use: analysis of national surveillance results
   Antimicrob Resist Infect Control, 3 (1), 40
   DOI 10.1186/s13756-014-0040-5, PubMed 25598971
5. Holst L, Havnen GC, Nordeng H (2014)
   Echinacea and elderberry-should they be used against upper respiratory tract infections during pregnancy?
   Front Pharmacol, 5, 31
   DOI 10.3389/fphar.2014.00031, PubMed 24624087
6. Hostrup M, Kalsen A, Bangsbo J, Hemmersbach P, Karlsson S, Backer V (2014)
   High-dose inhaled terbutaline increases muscle strength and enhances maximal sprint performance in trained men
   Eur J Appl Physiol, 114 (12), 2499-508
   DOI 10.1007/s00421-014-2970-2, PubMed 25113095
7. Hostrup M, Kalsen A, Ortenblad N, Juel C, Mørch K, Rzeppa S, Karlsson S, Backer V, Bangsbo J (2014)
   β2-adrenergic stimulation enhances Ca2+ release and contractile properties of skeletal muscles, and counteracts exercise-induced reductions in Na+-K+-ATPase Vmax in trained men
   J Physiol, 592 (24), 5445-59
   DOI 10.1113/jphysiol.2014.277095, PubMed 25344552
8. Hullstein I, Sagredo C, Hemmersbach P (2014)
   Carbon isotope ratios of nandrolone, boldenone, and testosterone preparations seized in Norway compared to those of endogenously produced steroids in a Nordic reference population
   Drug Test Anal, 6 (11-12), 1163-9
   DOI 10.1002/dta.1745, PubMed 25388436
9. Husøy MA, Brinch L, Tjønnfjord GE, Gedde-Dahl T, Heldal D, Holme PA, Dybedal I, Kolstad A, Akkök ÇA, Rollag H, Gaustad P, Bergan S, Egeland T, Josefsen D, Kvalheim G, Fløisand Y (2014)
   [Allogeneic stem-cell transplantation in adults 1985-2012: results and development]
   Tidsskr Nor Laegeforen, 134 (16), 1569-75
   DOI 10.4045/tidsskr.13.1415, PubMed 25178233
10. Høgmoen Åstrand OA, Gikling I, Sylte I, Rustan AC, Thoresen GH, Rongved P, Kase ET (2014)
    Development of new LXR modulators that regulate LXR target genes and reduce lipogenesis in human cell models
    Eur J Med Chem, 74, 258-63
    DOI 10.1016/j.ejmech.2014.01.003, PubMed 24480357
11. Høiseth G, Fjeld B, Burns ML, Strand DH, Vindenes V (2014)
    Long-term stability of morphine, codeine, and 6-acetylmorphine in real-life whole blood samples, stored at -20°C
    Forensic Sci Int, 239, 6-10
    DOI 10.1016/j.forsciint.2014.03.008, PubMed 24709028
12. Jendresen CB, Cui H, Zhang X, Vlodavsky I, Nilsson LN, Li JP (2014)
    Overexpression of heparanase lowers the amyloid burden in amyloid-β precursor protein transgenic mice
    J Biol Chem, 290 (8), 5053-64
    DOI 10.1074/jbc.M114.600569, PubMed 25548284
13. Kalsen A, Hostrup M, Karlsson S, Hemmersbach P, Bangsbo J, Backer V (2014)
    Effect of inhaled terbutaline on substrate utilization and 300-kcal time trial performance
    J Appl Physiol (1985), 117 (10), 1180-7
    DOI 10.1152/japplphysiol.00635.2014, PubMed 25257871
14. Kringen MK, Piehler AP, Grimholt RM, Opdal MS, Haug KB, Urdal P (2014)
    Serum bilirubin concentration in healthy adult North-Europeans is strictly controlled by the UGT1A1 TA-repeat variants
    PLoS One, 9 (2), e90248
    DOI 10.1371/journal.pone.0090248, PubMed 24587300
15. Levinsen M, Rotevatn EØ, Rosthøj S, Nersting J, Abrahamsson J, Appell ML, Bergan S, Bechensteen AG, Harila-Saari A, Heyman M, Jonsson OG, Maxild JB, Niemi M, Söderhäll S, Schmiegelow K, Nordic Society of Paediatric Haematology, Oncology (2014)
    Pharmacogenetically based dosing of thiopurines in childhood acute lymphoblastic leukemia: influence on cure rates and risk of second cancer
    Pediatr Blood Cancer, 61 (5), 797-802
    DOI 10.1002/pbc.24921, PubMed 24395436
16. Liu F, Qimuge, Hao J, Yan H, Bach T, Fan L, Morigen (2014)
    AspC-mediated aspartate metabolism coordinates the Escherichia coli cell cycle
    PLoS One, 9 (3), e92229
    DOI 10.1371/journal.pone.0092229, PubMed 24670900
17. Lunde I, Bremer S, Midtvedt K, Mohebi B, Dahl M, Bergan S, Åsberg A, Christensen H (2014)
    The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients
    Eur J Clin Pharmacol, 70 (6), 685-93
    DOI 10.1007/s00228-014-1656-3, PubMed 24658827
18. Melsom CB, Hussain RI, Ørstavik Ø, Aronsen JM, Sjaastad I, Skomedal T, Osnes JB, Levy FO, Krobert KA (2014)
    Non-classical regulation of β1- and β 2-adrenoceptor-mediated inotropic responses in rat heart ventricle by the G protein Gi
    Naunyn Schmiedebergs Arch Pharmacol, 387 (12), 1177-86
    DOI 10.1007/s00210-014-1036-7, PubMed 25216690
19. Melsom CB, Ørstavik Ø, Osnes JB, Skomedal T, Levy FO, Krobert KA (2014)
    Gi proteins regulate adenylyl cyclase activity independent of receptor activation
    PLoS One, 9 (9), e106608
    DOI 10.1371/journal.pone.0106608, PubMed 25203113
20. Moltzau LR, Aronsen JM, Meier S, Skogestad J, Ørstavik Ø, Lothe GB, Sjaastad I, Skomedal T, Osnes JB, Levy FO, Qvigstad E (2014)
    Different compartmentation of responses to brain natriuretic peptide and C-type natriuretic peptide in failing rat ventricle
    J Pharmacol Exp Ther, 350 (3), 681-90
    DOI 10.1124/jpet.114.214882, PubMed 25022512
21. Moltzau LR, Meier S, Aronsen JM, Afzal F, Sjaastad I, Skomedal T, Osnes JB, Levy FO, Qvigstad E (2014)
    Differential regulation of C-type natriuretic peptide-induced cGMP and functional responses by PDE2 and PDE3 in failing myocardium
    Naunyn Schmiedebergs Arch Pharmacol, 387 (5), 407-17
    DOI 10.1007/s00210-013-0953-1, PubMed 24424715
22. Narum S, Westergren T, Klemp M (2014)
    Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis
    BMJ Open, 4 (5), e004587
    DOI 10.1136/bmjopen-2013-004587, PubMed 24833682
23. Nuruddin S, Syverstad GH, Lillehaug S, Leergaard TB, Nilsson LN, Ropstad E, Krogenæs A, Haraldsen IR, Torp R (2014)
    Elevated mRNA-levels of gonadotropin-releasing hormone and its receptor in plaque-bearing Alzheimer's disease transgenic mice
    PLoS One, 9 (8), e103607
    DOI 10.1371/journal.pone.0103607, PubMed 25089901
24. Orstavik O, Ata SH, Riise J, Dahl CP, Andersen GØ, Levy FO, Skomedal T, Osnes JB, Qvigstad E (2014)
    Inhibition of phosphodiesterase-3 by levosimendan is sufficient to account for its inotropic effect in failing human heart
    Br J Pharmacol, 171 (23), 5169-81
    DOI 10.1111/bph.12647, PubMed 24547784
25. Robertsen I, Asberg A, Granseth T, Vethe NT, Akhlaghi F, Ghareeb M, Molden E, Reier-Nilsen M, Holdaas H, Midtvedt K (2014)
    More potent lipid-lowering effect by rosuvastatin compared with fluvastatin in everolimus-treated renal transplant recipients
    Transplantation, 97 (12), 1266-71
    DOI 10.1097/01.TP.0000443225.66960.7e, PubMed 24521776
26. Smith R, Solberg R, Jacobsen LL, Voreland AL, Rustan AC, Thoresen GH, Johansen HT (2014)
    Simvastatin inhibits glucose metabolism and legumain activity in human myotubes
    PLoS One, 9 (1), e85721
    DOI 10.1371/journal.pone.0085721, PubMed 24416446
27. Stormo C, Kringen MK, Lyle R, Olstad OK, Sachse D, Berg JP, Piehler AP (2014)
    RNA-sequencing analysis of HepG2 cells treated with atorvastatin
    PLoS One, 9 (8), e105836
    DOI 10.1371/journal.pone.0105836, PubMed 25153832
28. Størset E, Holford N, Hennig S, Bergmann TK, Bergan S, Bremer S, Åsberg A, Midtvedt K, Staatz CE (2014)
    Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling
    Br J Clin Pharmacol, 78 (3), 509-23
    DOI 10.1111/bcp.12361, PubMed 25279405
29. Sulheim D, Fagermoen E, Winger A, Andersen AM, Godang K, Müller F, Rowe PC, Saul JP, Skovlund E, Øie MG, Wyller VB (2014)
    Disease mechanisms and clonidine treatment in adolescent chronic fatigue syndrome: a combined cross-sectional and randomized clinical trial
    JAMA Pediatr, 168 (4), 351-60
    DOI 10.1001/jamapediatrics.2013.4647, PubMed 24493300
30. Sæves I, Line PD, Bremer S, Vethe NT, Tveit RG, Meltevik TJ, Bergan S (2014)
    Tacrolimus exposure and mycophenolate pharmacokinetics and pharmacodynamics early after liver transplantation
    Ther Drug Monit, 36 (1), 46-53
    DOI 10.1097/FTD.0b013e31829dcb66, PubMed 24081206
31. Vethe NT, Ali AM, Reine PA, Andersen AM, Bremer S, Line PD, Rootwelt H, Bergan S (2014)
    Simultaneous quantification of IMPDH activity and purine bases in lymphocytes using LC-MS/MS: assessment of biomarker responses to mycophenolic acid
    Ther Drug Monit, 36 (1), 108-18
    DOI 10.1097/FTD.0b013e3182a13900, PubMed 24061448
32. Westergren T, Hjelmeland K, Kristoffersen B, Johannessen SI, Kalikstad B (2014)
    Probable topiramate-induced diarrhea in a 2-month-old breast-fed child - A case report
    Epilepsy Behav Case Rep, 2, 22-3
    DOI 10.1016/j.ebcr.2013.12.006, PubMed 25667861
33. Ytrehus K, Larsen T, Christensen G, Stensløkken KO, Levy FO (2014)
    In memory of Guro Valen (1960-2014)
    J Mol Cell Cardiol, 79, 254-5
    DOI 10.1016/j.yjmcc.2014.11.026, PubMed 25490150

Publications 2013

1. Bach T, Bergholtz S, Riise J, Qvigstad E, Skomedal T, Osnes JB, Levy FO (2013)
   Identification of small molecule NPR-B antagonists by high throughput screening--potential use in heart failure
   Naunyn Schmiedebergs Arch Pharmacol, 387 (1), 5-14
   DOI 10.1007/s00210-013-0940-6, PubMed 24297249
2. Dehnes Y, Shalina A, Myrvold L (2013)
   Detection of recombinant EPO in blood and urine samples with EPO WGA MAIIA, IEF and SAR-PAGE after microdose injections
   Drug Test Anal, 5 (11-12), 861-9
   DOI 10.1002/dta.1579, PubMed 24190107
3. Eibye K, Elers J, Pedersen L, Henninge J, Hemmersbach P, Dalhoff K, Backer V (2013)
   Formoterol concentrations in blood and urine: the World Anti-Doping Agency 2012 regulations
   Med Sci Sports Exerc, 45 (1), 16-22
   DOI 10.1249/MSS.0b013e318269fba2, PubMed 22843108
4. Gravning J, Ahmed MS, Qvigstad E, Krobert K, Edvardsen T, Moe IT, Hagelin EM, Sagave J, Valen G, Levy FO, Osnes JB, Skomedal T, Attramadal H (2013)
   Connective tissue growth factor/CCN2 attenuates β-adrenergic receptor responsiveness and cardiotoxicity by induction of G protein-coupled receptor kinase-5 in cardiomyocytes
   Mol Pharmacol, 84 (3), 372-83
   DOI 10.1124/mol.113.087312, PubMed 23778361
5. Gu GJ, Wu D, Lund H, Sunnemark D, Kvist AJ, Milner R, Eckersley S, Nilsson LN, Agerman K, Landegren U, Kamali-Moghaddam M (2013)
   Elevated MARK2-dependent phosphorylation of Tau in Alzheimer's disease
   J Alzheimers Dis, 33 (3), 699-713
   DOI 10.3233/JAD-2012-121357, PubMed 23001711
6. Gumucio A, Lannfelt L, Nilsson LN (2013)
   Lack of exon 10 in the murine tau gene results in mild sensorimotor defects with aging
   BMC Neurosci, 14, 148
   DOI 10.1186/1471-2202-14-148, PubMed 24261309
7. Henning O, Baftiu A, Johannessen SI, Landmark CJ (2013)
   Withdrawal of antiepileptic drugs during presurgical video-EEG monitoring: an observational study for evaluation of current practice at a referral center for epilepsy
   Acta Neurol Scand, 129 (4), 243-51
   DOI 10.1111/ane.12179, PubMed 23980664
8. Hostrup M, Kalsen A, Auchenberg M, Rzeppa S, Hemmersbach P, Bangsbo J, Backer V (2013)
   Urine concentrations of oral salbutamol in samples collected after intense exercise in endurance athletes
   Drug Test Anal, 6 (6), 528-32
   DOI 10.1002/dta.1568, PubMed 24166762
9. Kalimo H, Lalowski M, Bogdanovic N, Philipson O, Bird TD, Nochlin D, Schellenberg GD, Brundin R, Olofsson T, Soliymani R, Baumann M, Wirths O, Bayer TA, Nilsson LN, Basun H, Lannfelt L, Ingelsson M (2013)
   The Arctic AβPP mutation leads to Alzheimer's disease pathology with highly variable topographic deposition of differentially truncated Aβ
   Acta Neuropathol Commun, 1, 60
   DOI 10.1186/2051-5960-1-60, PubMed 24252272
10. Karouni M, Henning O, Larsson PG, Johannessen SI, Johannessen Landmark C (2013)
    Pharmacological treatment of psychiatric comorbidity in patients with refractory epilepsy
    Epilepsy Behav, 29 (1), 77-81
    DOI 10.1016/j.yebeh.2013.06.031, PubMed 23939032
11. Kvehaugen AS, Melien Ø, Holmen OL, Laivuori H, Dechend R, Staff AC (2013)
    PP084. Hypertension after preeclampsia in women with C1114G polymorphism in rgs2 (the regulator of g protein signaling 2)
    Pregnancy Hypertens, 3 (2), 98
    DOI 10.1016/j.preghy.2013.04.109, PubMed 26105937
12. Levy FO (2013)
    Cardiac PDEs and crosstalk between cAMP and cGMP signalling pathways in the regulation of contractility
    Naunyn Schmiedebergs Arch Pharmacol, 386 (8), 665-70
    DOI 10.1007/s00210-013-0874-z, PubMed 23649864
13. Lillehaug S, Syverstad GH, Nilsson LN, Bjaalie JG, Leergaard TB, Torp R (2013)
    Brainwide distribution and variance of amyloid-beta deposits in tg-ArcSwe mice
    Neurobiol Aging, 35 (3), 556-64
    DOI 10.1016/j.neurobiolaging.2013.09.013, PubMed 24126157
14. Lillenes MS, Støen M, Gómez-Muñoz M, Torp R, Günther CC, Nilsson LN, Tønjum T (2013)
    Transient OGG1, APE1, PARP1 and Polβ expression in an Alzheimer's disease mouse model
    Mech Ageing Dev, 134 (10), 467-77
    DOI 10.1016/j.mad.2013.09.002, PubMed 24121118
15. Lund H, Snilsberg AH, Halvorsen TG, Hemmersbach P, Reubsaet L (2013)
    Comparison of newly developed immuno-MS method with existing DELFIA(®) immunoassay for human chorionic gonadotropin determination in doping analysis
    Bioanalysis, 5 (5), 623-30
    DOI 10.4155/bio.13.8, PubMed 23425277
16. Lærum H, Bremer S, Bergan S, Grünfeld T (2013)
    A taste of individualized medicine: physicians' reactions to automated genetic interpretations
    J Am Med Inform Assoc, 21 (e1), e143-6
    DOI 10.1136/amiajnl-2012-001587, PubMed 24001515
17. Magnusson K, Sehlin D, Syvänen S, Svedberg MM, Philipson O, Söderberg L, Tegerstedt K, Holmquist M, Gellerfors P, Tolmachev V, Antoni G, Lannfelt L, Hall H, Nilsson LN (2013)
    Specific uptake of an amyloid-β protofibril-binding antibody-tracer in AβPP transgenic mouse brain
    J Alzheimers Dis, 37 (1), 29-40
    DOI 10.3233/JAD-130029, PubMed 23780660
18. Moltzau LR, Aronsen JM, Meier S, Nguyen CH, Hougen K, Ørstavik Ø, Sjaastad I, Christensen G, Skomedal T, Osnes JB, Levy FO, Qvigstad E (2013)
    SERCA2 activity is involved in the CNP-mediated functional responses in failing rat myocardium
    Br J Pharmacol, 170 (2), 366-79
    DOI 10.1111/bph.12282, PubMed 23808942
19. Narum S, Solhaug V, Myhr K, Brørs O, Kringen MK (2013)
    Characterisation of non-warfarin-associated bleeding events reported to the Norwegian spontaneous reporting system
    Eur J Clin Pharmacol, 69 (7), 1445-52
    DOI 10.1007/s00228-013-1479-7, PubMed 23423243
20. Reine PA, Vethe NT, Kongsgaard UE, Andersen AM, Line PD, Ali AM, Bergan S (2013)
    Mycophenolate pharmacokinetics and inosine monophosphate dehydrogenase activity in liver transplant recipients with an emphasis on therapeutic drug monitoring
    Scand J Clin Lab Invest, 73 (2), 117-24
    DOI 10.3109/00365513.2012.745947, PubMed 23281843
21. Rogeberg M, Malerod H, Roberg-Larsen H, Aass C, Wilson SR (2013)
    On-line solid phase extraction-liquid chromatography, with emphasis on modern bioanalysis and miniaturized systems
    J Pharm Biomed Anal, 87, 120-9
    DOI 10.1016/j.jpba.2013.05.006, PubMed 23746991
22. Stormo C, Bogsrud MP, Hermann M, Åsberg A, Piehler AP, Retterstøl K, Kringen MK (2013)
    UGT1A1*28 is associated with decreased systemic exposure of atorvastatin lactone
    Mol Diagn Ther, 17 (4), 233-7
    DOI 10.1007/s40291-013-0031-x, PubMed 23580084
23. Strand OA, Sandberg M, Sylte I, Görbitz CH, Thoresen GH, Kase ET, Rongved P (2013)
    Synthesis and initial biological evaluation of new mimics of the LXR-modulator 22(S)-hydroxycholesterol
    Bioorg Med Chem, 22 (1), 643-50
    DOI 10.1016/j.bmc.2013.10.024, PubMed 24268541
24. Størset E, Holford N, Midtvedt K, Bremer S, Bergan S, Åsberg A (2013)
    Importance of hematocrit for a tacrolimus target concentration strategy
    Eur J Clin Pharmacol, 70 (1), 65-77
    DOI 10.1007/s00228-013-1584-7, PubMed 24071959
25. Sørensen O, Andersen AM, Kristian A, Giercksky KE, Flatmark K (2013)
    Impact of hyperthermia on pharmacokinetics of intraperitoneal mitomycin C in rats investigated by microdialysis
    J Surg Oncol, 109 (6), 521-6
    DOI 10.1002/jso.23527, PubMed 24347444
26. Åsberg A, Midtvedt K, van Guilder M, Størset E, Bremer S, Bergan S, Jelliffe R, Hartmann A, Neely MN (2013)
    Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantation
    Transpl Int, 26 (12), 1198-207
    DOI 10.1111/tri.12194, PubMed 24118301
27. Aasrum M, Ødegård J, Sandnes D, Christoffersen T (2013)
    The involvement of the docking protein Gab1 in mitogenic signalling induced by EGF and HGF in rat hepatocytes
    Biochim Biophys Acta, 1833 (12), 3286-3294
    DOI 10.1016/j.bbamcr.2013.10.004, PubMed 24126105

Publications 2012

1. Askim M, Haug A, Gadeholt G (2012)
   Dietary intake of menaquinone-4 may determine hepatic and pancreatic menaquinone-4 in chickens
   Food Nutr Res, 56
   DOI 10.3402/fnr.v56i0.5380, PubMed 22481898
2. Bernard JP, Havnes I, Slørdal L, Waal H, Mørland J, Khiabani HZ (2012)
   Methadone-related deaths in Norway
   Forensic Sci Int, 224 (1-3), 111-6
   DOI 10.1016/j.forsciint.2012.11.010, PubMed 23246070
3. Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS (2012)
   Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI)
   Epilepsy Res, 103 (1), 2-30
   DOI 10.1016/j.eplepsyres.2012.10.001, PubMed 23219031
4. Brattelid T, Qvigstad E, Moltzau LR, Bekkevold SV, Sandnes DL, Birkeland JA, Skomedal T, Osnes JB, Sjaastad I, Levy FO (2012)
   The cardiac ventricular 5-HT4 receptor is functional in late foetal development and is reactivated in heart failure
   PLoS One, 7 (9), e45489
   DOI 10.1371/journal.pone.0045489, PubMed 23029047
5. Danese E, Montagnana M, Johnson JA, Rettie AE, Zambon CF, Lubitz SA, Suarez-Kurtz G, Cavallari LH, Zhao L, Huang M, Nakamura Y, Mushiroda T, Kringen MK, Borgiani P, Ciccacci C, Au NT, Langaee T, Siguret V, Loriot MA, Sagreiya H, Altman RB, Shahin MH, Scott SA, Khalifa SI, Chowbay B et al. (2012)
   Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis
   Clin Pharmacol Ther, 92 (6), 746-56
   DOI 10.1038/clpt.2012.184, PubMed 23132553
6. Elers J, Hostrup M, Pedersen L, Henninge J, Hemmersbach P, Dalhoff K, Backer V (2012)
   Urine and serum concentrations of inhaled and oral terbutaline
   Int J Sports Med, 33 (12), 1026-33
   DOI 10.1055/s-0032-1311590, PubMed 22782385
7. Elers J, Pedersen L, Henninge J, Hemmersbach P, Dalhoff K, Backer V (2012)
   The pharmacokinetic profile of inhaled and oral salbutamol in elite athletes with asthma and nonasthmatic subjects
   Clin J Sport Med, 22 (2), 140-5
   DOI 10.1097/JSM.0b013e31823513e1, PubMed 22388343
8. Fjeld B, Burns ML, Karinen R, Larssen B, Smith-Kielland A, Vindenes V (2012)
   Long-term stability of GHB in post-mortem samples and samples from living persons, stored at -20°C, using fluoride preservatives
   Forensic Sci Int, 222 (1-3), 47-51
   DOI 10.1016/j.forsciint.2012.04.033, PubMed 22648054
9. Fretheim A, Odgaard-Jensen J, Brørs O, Madsen S, Njølstad I, Norheim OF, Svilaas A, Kristiansen IS, Thürmer H, Flottorp S (2012)
   Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis
   BMC Med, 10, 33
   DOI 10.1186/1741-7015-10-33, PubMed 22480336
10. Gellynck E, Andressen KW, Lintermans B, Haegeman G, Levy FO, Vanhoenacker P, Van Craenenbroeck K (2012)
    Biochemical and pharmacological study of N-linked glycosylation of the human serotonin 5-HT₇a receptor
    FEBS J, 279 (11), 1994-2003
    DOI 10.1111/j.1742-4658.2012.08581.x, PubMed 22448645
11. Gjersvik P, Helsing P, Holdaas H, Bergan S (2012)
    [Immunosuppressive drugs and the development of skin cancer after organ transplantation]
    Tidsskr Nor Laegeforen, 132 (18), 2064-8
    DOI 10.4045/tidsskr.12.0389, PubMed 23038197
12. Gustavsen I, Hjelmeland K, Bernard JP, Mørland J (2012)
    Individual psychomotor impairment in relation to zopiclone and ethanol concentrations in blood--a randomized controlled double-blinded trial
    Addiction, 107 (5), 925-32
    DOI 10.1111/j.1360-0443.2011.03693.x, PubMed 22008377
13. Hemmersbach P, Drange M, Rabin O, Botrè F, Dehnes Y (2012)
    Doping analysis on solid ground
    Tidsskr Nor Laegeforen, 132 (2), 130
    DOI 10.4045/tidsskr.11.1330, PubMed 22278263
14. Holmboe L, Andersen AM, Mørkrid L, Slørdal L, Hall KS (2012)
    High dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patients
    Br J Clin Pharmacol, 73 (1), 106-14
    DOI 10.1111/j.1365-2125.2011.04054.x, PubMed 21707700
15. Hussain RI, Aronsen JM, Afzal F, Sjaastad I, Osnes JB, Skomedal T, Levy FO, Krobert KA (2012)
    The functional activity of inhibitory G protein (G(i)) is not increased in failing heart ventricle
    J Mol Cell Cardiol, 56, 129-38
    DOI 10.1016/j.yjmcc.2012.11.015, PubMed 23220156
16. Johannessen Landmark C, Baftiu A, Tysse I, Valsø B, Larsson PG, Rytter E, Johannessen SI (2012)
    Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication
    Ther Drug Monit, 34 (4), 440-5
    DOI 10.1097/FTD.0b013e31825ee389, PubMed 22777154
17. Kringen MK, Stormo C, Grimholt RM, Berg JP, Piehler AP (2012)
    Copy number variations of the ATP-binding cassette transporter ABCC6 gene and its pseudogenes
    BMC Res Notes, 5, 425
    DOI 10.1186/1756-0500-5-425, PubMed 22873774
18. Lei P, Baysa A, Nebb HI, Valen G, Skomedal T, Osnes JB, Yang Z, Haugen F (2012)
    Activation of Liver X receptors in the heart leads to accumulation of intracellular lipids and attenuation of ischemia-reperfusion injury
    Basic Res Cardiol, 108 (1), 323
    DOI 10.1007/s00395-012-0323-z, PubMed 23266787
19. Lund H, Snilsberg AH, Paus E, Halvorsen TG, Hemmersbach P, Reubsaet L (2012)
    Sports drug testing using immuno-MS: clinical study comprising administration of human chorionic gonadotropin to males
    Anal Bioanal Chem, 405 (5), 1569-76
    DOI 10.1007/s00216-012-6566-6, PubMed 23203507
20. Nilsson LN, Gografe S, Costa DA, Hughes T, Dressler D, Potter H (2012)
    USE OF FUSED CIRCULATIONS TO INVESTIGATE THE ROLE OF APOLIPOPROTEIN E AS AMYLOID CATALYST AND PERIPHERAL SINK IN ALZHEIMER'S DISEASE
    Technol Innov, 14 (2), 199-208
    DOI 10.3727/194982412X13462021398010, PubMed 23626867
21. Opdal MS (2012)
    [Sick from sickness, substance abuse or medicine]
    Tidsskr Nor Laegeforen, 132 (1), 52
    DOI 10.4045/tidsskr.11.0906, PubMed 22240832
22. Riise J, Ørstavik Ø, Qvigstad E, Dahl CP, Osnes JB, Skomedal T, Levy FO, Krobert KA (2012)
    Prostaglandin E1 facilitates inotropic effects of 5-HT4 serotonin receptors and β-adrenoceptors in failing human heart
    Basic Res Cardiol, 107 (5), 295
    DOI 10.1007/s00395-012-0295-z, PubMed 22923058
23. Stormo C, Kringen MK, Grimholt RM, Berg JP, Piehler AP (2012)
    A novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) splice variant with an alternative exon 1 potentially encoding an extended N-terminus
    BMC Mol Biol, 13, 29
    DOI 10.1186/1471-2199-13-29, PubMed 22989091
24. Sæves I, Line PD, Bergan S (2012)
    The pharmacokinetics of prednisolone and prednisone in adult liver transplant recipients early after transplantation
    Ther Drug Monit, 34 (4), 452-9
    DOI 10.1097/FTD.0b013e31825ee3f8, PubMed 22777155
25. Zhang X, Wang B, O'Callaghan P, Hjertström E, Jia J, Gong F, Zcharia E, Nilsson LN, Lannfelt L, Vlodavsky I, Lindahl U, Li JP (2012)
    Heparanase overexpression impairs inflammatory response and macrophage-mediated clearance of amyloid-β in murine brain
    Acta Neuropathol, 124 (4), 465-78
    DOI 10.1007/s00401-012-0997-1, PubMed 22692572